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Abstract
The invention of next generation sequencing (NGS) revolutionized the field
of human genetics, providing a practical way to study genetics in a genome-
wide fashion. With the ability to sequence the whole genome came the ability
to observe the epigenome, the patterns and interactions of epigenetic signa-
tures across the whole genome. Over the years, existing epigenetic methods
have been adapted to NGS, and new approaches of using NGS to study
the epigenome have been demonstrated. Now NGS-based studies are gold
standards in studying the human epigenome.
Despite the advances in our understanding of the human epigenome,
many gaps still remain. The epigenome is composed of numerous chemical
components, and the observed phenotype is a result of complex interactions of
these epigenetic features. The epigenome is also highly heterogeneous, further
complicating the analysis of epigenetic interactions. In addition, limitations
of our understanding of the genome, e.g. repetitive elements, centromeric
regions, and large-scale genomic rearrangements, is translated directly to the
lack of understanding of their epigenome.
The emergence of nanopore sequencing has opened new doors for study-
ing the human genome and epigenome. Here I describe how I adapted NGS
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epigenomic methods to nanopore sequencing, and how this furthers our
knowledge of the epigenome. I first present the application of nanopore
sequencing in observing multiple layers of epigenetic information and un-
covering epigenetic patterns across the genome. Then I show the utility of
the long read in studying the epigenome, observing allele-specific epigenetic
patterns on single-molecules. Lastly, I implemented targeted sequencing on
nanopore to generate deep sequencing coverage in select genomic regions and
its usage in variant detection.
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When Conrad Waddington first coined the term “epigenetics” in 1942, he used
it to broadly describe the mechanisms and processes linking the genotype and
the phenotype (Waddington, 1942). As the field matured, this definition of
epigenetics has evolved as well, now commonly being defined as potentially
heritable features of the DNA other than the actual sequence that affect the
function of the genome (Murrell, Rakyan, and Beck, 2005; Bernstein, Meissner,
and Lander, 2007). In turn, the epigenome refers to the patterns and interac-
tions of epigenetic features across the whole genome (Beck, Olek, and Walter,
1999). Despite the recent advances in the field and our better understanding
of the epigenome, we still lack a clear understanding of how the many facets
of the epigenome complement and interact with each other to regulate gene
expression(Crews and Gore, 2014; Ng and Bird, 1999; Bell and Felsenfeld,
2000).
DNA methylation is a covalent modification of a DNA nucleotide residue
by addition of a methyl group to the base. In mammals, the most prominent
type of DNA methylation is cytosine methylation in CG dinucleotide contexts,
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simply referred to as CpG methylation (Jones and Takai, 2001). DNA is also
organized inside the nucleus by protein molecules called histones, and the
DNA wrapped around complexes of histone molecules form packaging of
chromatin termed nucleosomes. The organization of nucleosomes and the
resulting differences in accessibility of chromatin govern the interactions of
regulatory genomic elements, such as enhancers, promoters, and transcription
factor binding motifs, with themselves and DNA-binding proteins (Klemm,
Shipony, and Greenleaf, 2019). Factors that influence the organization of chro-
matin include, but are not limited to, covalent modifications on the N-terminal
tails of histone molecules, interaction of DNA with the nuclear periphery,
and binding of specific chromatin-remodeling proteins such as CTCF and
cohesin (Kouzarides, 2007; Mattout-Drubezki and Gruenbaum, 2003; Rowley
and Corces, 2018).
Because the epigenome influences which part of the genome is active, it has
implications in many diseases and medical conditions (Robertson, 2005). One
notable example of this is cancer: alterations in the epigenome are routinely
observed in cancer (Hanahan and Weinberg, 2011). Global hypomethylation
and hypermethylation of tumor supperssor gene promoters are some of the
distinguishing epigenomic characteristics of cancer (Feinberg and Vogelstein,
1983; Baylin et al., 1986). Subsequent studies found that increase in variabil-
ity and dysregulation of the epigenome contribute to these changes in the
epigenome that promote tumorigenesis (Hansen et al., 2011; Landan et al.,
2012; Timp and Feinberg, 2013). Another example is imprinting disorders:
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because imprinting, or parent-of-origin specific expression of a gene, is main-
tained by the epigenome, conditions related to dysregulation of imprinting
often have aberrant epigenetic signatures (Walter and Paulsen, 2003).
Discoveries of the role of the epigenome in diseases could not have been
achieved without developments and advancements in epigenetic assays. Treat-
ment of genomic DNA with methylation-sensitive restriction enzymes that
have different cleaving capabilities depending on the methylation state of the
recognition sequence, such as HpaII and HhaI, was one of the first methods
used to detect CpG methylation, and is still a popular method to verify methy-
lation states due to the robustness and low cost of the assay (Bird and Southern,
1978). In the early days of DNA sequencing, bisulfite conversion, in which
methylated cytosine residues are protected from the conversion of unmethy-
lated cytosine residues to uracil residues, became a popular method to couple
DNA sequencing with methylation detection (Frommer et al., 1992). Then
came microarray technology which, when coupled to methylation-sensitive
restriction digestion or bisulfite conversion, allowed the first genome-wide as-
sessment of DNA methylation using a single assay, in the sense that thousands
of CpG sites across the genome could be examined (Gitan et al., 2002; Weber
et al., 2005; Irizarry et al., 2008). Nucleosome organization and chromatin
accessibility could be measured by treating intact nuclei with nucleases such
as DNAse I and micrococcal nuclease Wu, 1980; Noll and Kornberg, 1977. The
occupancy of DNA by proteins, i.e. histones, protects the DNA from these
nucleases and only the open chromatin are cleaved, in the case of DNAse I,
or digested away, in the case of micrococcal nuclease. The remaining short
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strands of DNA could then be assessed using PCR or microarrays (Schones
et al., 2008; Lee et al., 2007).
But, the entire landscape of genomics was revolutionized with the intro-
duction of massively parallel DNA sequencing. Massively parallel sequencing,
more commonly referred nowadays as Next Generation Sequencing (NGS),
uses a fluidic device to simultaneously sequence millions of DNA strands at
the same time (Margulies et al., 2005). Briefly, millions of DNA strands attach
to the bottom of the flow cell and are amplified to generate clusters of DNA
with strands within a cluster having identical sequences. Then the complemen-
tary strand of the DNA is synthesized one nucleotide at a time using reversible
terminators, which are nucleotide molecules that prevent further extension.
The nucleotide molecules also are labeled with fluorophores that emits light
at a wavelength as the nucleotide gets incorporated. The multiple strands
in each cluster amplifies the emitted signal, and the signals from millions of
clusters are picked up by highly sensitive optical instruments. This process
of sequencing by synthesis is repeated over and over until the full sequences
of the strands are synthesized. This automated, highly parallel technology
dramatically reduced the cost of DNA sequencing, making true whole genome
sequencing of organisms with large genomes such as humans affordable. With
the proliferation of NGS, many epigenetic assays were adapted to NGS to
measure the epigenetic features across the genome, allowing true observation
of the whole epigenome (Maunakea, Chepelev, and Zhao, 2010). Bisulfite se-
quencing, which had been applied on PCR and microarray technologies, was
adapted to NGS as Whole Genome Bisulfite Sequencing (WGBS), allowing
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genome-wide, single-base-resolution maps of human methylome (Lister et al.,
2009). Existing chromatin assays were also adapted to NGS as whole genome
enrichment sequencing methodologies, such as DNAse-seq and MNase-seq,
to allow genome-wide assessment of chromatin organization (Boyle et al.,
2008; Henikoff et al., 2011).
Though a tremendous advance, NGS still has limitations centered around
the short lengths of its reads. This results in gaps in our knowledge; NGS-
based epigenomic assays are unsuitable for studying repetitive elements and
structural variations. Also, due to the highly heterogeneous nature of the
epigenome, it has been difficult to directly link changes in the epigenome
with phenotypic effects (Lai and Pugh, 2017; Buenrostro et al., 2015). Single-
cell approaches have shown promise in navigating this heterogeneity, but
because most human cells have two - or more, i.e. aneulploidy, - copies of
each chromosome, these approaches still fail to resolve all of the heterogeneity.
Lastly, the epigenome is composed of interactions of numerous components,
but most epigenomic assays probe one of the epigenetic features (Bernstein,
Meissner, and Lander, 2007).
Nanopore sequencing is a third generation of DNA sequencing technology
that uses a transmembrane ion channel protein to characterize DNA molecules,
where DNA sequences are detected in forms of electrolytic current modulation
as molecules pass through a nanopore (Branton et al., 2009; Timp et al., 2010;
Mikheyev and Tin, 2014). As the DNA strands pass through the protein
molecule, which is large enough only for one single stranded DNA molecule
at a time, the change in the current through the membrane is measured.
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Multiple bases are within the central constriction of the pore at a given time
(“k-mers”) and the characteristic current signature given by each k-mer is
deciphered (a.k.a base-called) into nucleotide sequences. Unlike sequencing
by synthesis, nanopore sequencing measures the molecule directly and can
detect covalent modifications on the DNA, such as CpG methylation (Simpson
et al., 2017). Also, nanopore generates long DNA sequences (reads), which
allows observing epigenetics of repetitive elements and structural variations
(Jain et al., 2018; Norris et al., 2016). We can observe interactions of epigenetic
features across the long length of single molecules, much like single-cell
epigenomic assays, and further separate the molecules within a cell (phase)
based on nearby non-homozygous variations (Gigante et al., 2019).
I leveraged nanopore sequencing to explore the human epigenome. I
applied exogenous labeling to simultaneously measure CpG methylation and
chromatin accessibility using nanopore sequencing, examining the epigenetic
features in parts of the genome that have not been extensively studied. Then I
exploited the long reads to explore the epigenome on an allele-specific and
single-molecule resolution. Finally, I applied targeted nanopore sequencing,




2) Single-molecule and 
Allele-specific Epigenomics





GpC MTase GpC MTase
1) Simultaneous Methylation and 
Chromatin Accessibility Detection
- Detection of multiple modifications
- Epigenetics of repetitive elements
- Comparative epigenetics
- Single-molecule accessibility smoothing
- Regulatory protein binding
- Single-molecule distant epigenetic ineteractions
- Phased epigenome
- High coverage nanopore sequencing on targeted regions
- Structural variation detection








































Figure 1.1: Overview of dissertation work.
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2.1 Abstract
Probing epigenetic features on long molecules of DNA has tremendous po-
tential to advance our understanding of the epigenome. In this section, we
evaluate CpG methylation and chromatin accessibility simultaneously on
long strands of DNA using GpC methyltransferase to exogenously label open
chromatin, coupled with nanopore sequencing technology. We describe the
procedures we used to train and test the model for calling CpG and GpC
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methylation simultaneously. We then describe nanopore sequencing of Nu-
cleosome Occupancy and Methylome (nanoNOMe) on four human cell lines
(GM12878, MCF-10A, MCF-7, MDA-MB-231), and demonstrate the ability to
directly measure methylation and chromatin accessibility in genomic features
such as structural variations and repetitive elements.
2.2 Introduction
With the proliferation of DNA sequencing technologies, methods have been
developed for examining nuclear organization, protein binding site occu-
pancy, chromatin accessibility, and methylation state using next generation
sequencing (NGS). Cytosine methylation at CG dinucleotide contexts (CpG
methylation) has been studied widely using bisulfite treatment coupled to
DNA sequencing (Frommer et al., 1992). In bisulfite sequencing, native ge-
nomic DNA undergoes bisulfite conversion, wherein unmethylated cytosine
residues are converted to uracil residues while methylated cytosine residues
are protected from this conversion. The resulting DNA sequences are compu-
tationally parsed to determine the methylation state, and despite the reduction
of DNA complexity due to the bisulfite conversion, advances in computational
algorithms have made the process highly accurate and reproducible (Krueger
and Andrews, 2011; Hansen, Langmead, and Irizarry, 2012).
Many methods for detecting chromatin accessibility and nucleosome po-
sitioning rely on the openness of accessible and nucleosome depleted chro-
matin to enzymatic treatments. DNAse-seq is a NGS adaptation of DNAse I
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hypersensitivity assay, which uses DNAse I to selectively cleave nucleosome-
depleted DNA and retrieve DNAse I hypersensitive sites (Boyle et al., 2008).
By amplifying the cleaved, short strands of DNA, the resulting DNA library
becomes enriched of the accessible chromatin, which is then sequenced to
observe the enrichment. Similarly, ATAC-seq exploits the accessibility of
cleaving enzymes to open chromatin; instead of DNAse I, ATAC-seq uses
Tn5 transposases to insert a predefined sequence to the open chromatin after
cleaving the site (Buenrostro et al., 2015). Then these predefined transposon
sequences are used as the template sequences for PCR, thereby selectively
amplifying the cleaved sites. The approach of MNase-seq is the opposite :
instead of cleaving and enriching the open chromatin, MNase digests away
the open chromatin, leaving only the inaccessible, nucleosome-occupied DNA
to be amplified and sequenced (Henikoff et al., 2011).
NOMe-seq uses a methyltransferase enzyme to exogenously label accessi-
ble chromatin (Kelly et al., 2012). The methyltransferase enzyme used in this
methodology, M. CviPI GpC methyltransferase, methylates cytosine residues
at GpC sites (GC dinucleotide contexts). While cytosine methylation is en-
dogenously present in mammalian genomes, because the vast majority of
endogenous cytosine methylation specifically occurs in CpG sites (CG dinu-
cleotide contexts), the GpC methylation can be separated as the exogenous
labeling motif. After bisulfite conversion and sequencing, the resulting data
contains both the endogenous CpG methylation and exogenously labeled
GpC accessibility. Therefore, NOMe-seq permits simultaneous evaluation of
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endogenous CpG methylation and nucleosome occupancy. Another distin-
guishing feature of NOMe-seq with regard to measuring chromatin accessi-
bility is that it does not rely on enrichment by PCR amplification. The usage
of covalent DNA modification rather than PCR enrichment makes this easily
adaptable to nanopore sequencing.
Nanopore sequencing is suitable for epigenomic studies because of its
ability to detect covalent modifications, as these modifications change the
chemical structure of the DNA molecule and hence the modulation of the
current by the molecule. We and others have previously shown that endoge-
nous CpG methylation can be accurately called with nanopore data (Simpson
et al., 2017; Rand et al., 2017). Another advantage of nanopore sequencing is
that it generates long reads, which allows a deeper analysis into long-range
patterns on individual molecules. More recently, this technology was applied
to exogenous labeling of chromatin accessibility, similar to in NOMe-seq, in
S. Cerevisiae, a unicellular eukaryotic model organism without endogenous
methylation (Shipony et al., 2020; Wang et al., 2019). To further the application
of nanopore sequencing in studying the epigenome, here we present nanopore
sequencing of Nucleosome Occupancy and Methylome (nanoNOMe), where
we label mammalian cells which have endogenous CpG methylation with ex-
ogenous GpC modifications at accessible sites. We are able to take advantage
of the long read lengths (>10kb) generated by nanopore sequencing to read
the CpG methylation and chromatin accessibility across stretches of genomic
regions at the single molecule level.
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2.3 Results
2.3.1 Development of nanopore methylation calling model
2.3.1.1 Methylation training and testing samples generation
The current gold standard method for detecting methylation on nanopore
sequencing data is nanopolish (Figure 2.1) (Simpson et al., 2017). Nanopolish
employs a hidden Markov model (HMM) to detect cytosine methylation based
on electrical current signatures (events) corresponding to groups of nucleotide
sequences (k-mers). The HMM uses a table of event level distributions, termed
a pore model, characteristic to every 6-mer to predict the methylation state
of the 6-mer. The original methylation pore model was designed to call cy-
tosine methylation at CG dinucleotide contexts (CpG methylation), which
is the endogenous methylation present in mammalian DNA (Simpson et al.,
2017). Extending the methylation caller to additionally call cytosine methyla-
tion at GC dinucleotide context (GpC methylation) required building a new
model able to handle four possible states for each 6-mer: 1) methylated at
CpG contexts, 2) methylated at GpC contexts, 3) methylated at both CpG
and GpC contexts, and 4) unmethylated at both contexts. Building a new
model required new training samples representing each methylation state. We
generated the training samples using combinations of M.SssI (CpG methyl-
transferase) and M. CviPI (GpC methyltransferase) on unmethylated (PCR
amplified) Escherichia coli (E. coli) genomic DNA (gDNA) (Figure 2.2). We
also generated testing samples in the same fashion on NA12878 human lym-
phoblast cell line gDNA. Testing samples are generated separately, on gDNA
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of an organism with more complex genome to ensure during testing that the
model has not been overtrained. To verify that the methylation was successful,
the training and testing sets were subjected to bisulfite sequencing on Illumina
Sequencing. After separating the cytosine motifs by the dinucleotide context
and calculating the fraction of methylated sites, we observed near-complete
methylation specifically at desired motifs (Figure 2.3).












Figure 2.1: Overview of methylation calling using nanopolish. The current signal
is converted in to the sequence, and then mapped to a reference genome. The resulting
alignment information and the raw current signal are both used to determine the
methylation state of the data
2.3.1.2 Training the CpG + GpC dual methylation caller
Once the quality of methylation samples were verified via Illumina sequenc-
ing, we sequenced the samples on a minION flowcell of nanopore sequencing.
We generated an average of 7.8 Gb of DNA sequences per sample, amounting
to an average of 1,300X of E. coli genome coverage and 3X of human genome
coverage (Supplementary Table 2.2). After processing the training data and
aligning to E. coli reference sequence, we tabulated the current modulations
(mA) for each alignment to a methylation motif (CpG and/or GpC) in the ref-
erence sequence. We observed that the different positions of the methylation
18
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Figure 2.2: Overview of methylation control sample generation. Genomic DNA
is amplified by PCR, generating (1) fully unmethylated DNA. On aliquots of the
unmethylated DNA, combinations of CpG and GpC methylation treatments are
performed using M. SssI for CpG and M. CviPI for GpC methylation, generating (2)
GpC methylated, (3) CpG methylated, and (4) CpG and GpC methylated samples
within 6-mers modulate the current to different extents, which we can use to
discriminate between CpG and GpC methylation in addition to methylated
and unmethylated states (Figure 2.4a, more examples in Supplementary Fig-
ure 2.20). We then tested for the dependence of the current modulation on
the position of the methylation within the 6-mer and found that the current
deviation from unmethylated 6-mers is weak when the methylation motif is at
the edge (1st and 6th position) and the strongest when it is on the 5th position
of the 6-mer (Figure 2.4b).
We then used the E. coli nanopore sequencing data to train the dual
CpG/GpC methylatin pore model. For each 6-mer in the reference sequence,
the posterior probability of an observed event was learned using the for-













































Figure 2.3: Fractions of methylated sites in training and testing samples. Fractions
of CpG and GpC sites in methylation training (E. coli) and testing (NA12878) sets
that were called as methylated by bisulfite sequencing.
Gaussian model to the distribution of the current modulations using the
expectation-maximization algorithm, with the contribution of each observa-
tion weighted by the calculated posterior probability. Fitting the Gaussian
model for each 6-mer in each dataset, we generated the pore models for the
four states of methylation.
2.3.1.3 Testing the methylation caller
We then used the methylation pore model to call methylation on the testing
sample dataset. To be able to call the two methylation motifs simultaneously
and also discriminate the two motifs, the methylation calling module in
nanopolish was modified. The first step of methylation calling is grouping
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Figure 2.4: Current modulations in training samples. The ability of nanopore se-
quencing to distinguish cytosine methylation at CpG and GpC contexts is shown
by (a) an example of shift in current modulations in the four training samples at
GCATCG 6-mer and (b) examining current level shifts depending on the placement
of the methylation on a 6-mer
the influence of adjacent methylation motif in the current modulation of
another motif. We then calculate a likelihood for combinations of the grouped
sites being methylated or unmethylated (either no sites methylated, all CpGs
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methylated, all GpCs methylated, or all sites both contexts methylated), using
the k-mer states trained in the previous section, with a profile HMM. Finally,
separate ratios of log-likelihoods (LLR) are calculated for the two methylation
motifs :
LogLikRatio(XCpG) = log(L(XCpG) + L(XCpGGpC))
− log(L(XGpC) + L(XUnmethylated))
LogLikRatio(XGpC) = log(L(XGpC) + L(XCpGGpC))
− log(L(XCpG) + L(XUnmethylated))
To benchmark the dual methylation detection, we called methylation on the
NA12878 testing sample data. After nanopore sequencing the same samples,
we first confirmed that full methylation does not decrease mappability of the
reads in nanopore sequencing (Supplementary Table 2.2). We observed that
the fraction of high-quality reads did not decrease in the methylated samples
in comparison to the unmethylated sample. We then tested the performance of
nanopolish by calulating the Receiver Operating Characteristic (ROC) curves
: we applied a range of LLR thresholds to bin the continuous LLR into the
binary state of methylated/unmethylated calls and compared the predictions
to the true state for each singularly methylated and the unmethylated data
Figure 2.5). Both CpG and GpC ROC had high areas under the curve (AUC)















Figure 2.5: Receiver Operating Characteristic of methylation calling. ROC curve
of methylation calling for a range of LLR thresholds on NA12878 modified with CpG
and GpC methylation.
To choose the LLR thresholds for determining the binary state of methyla-
tion (methylated vs unmethylated) from the continuous LLRs, we separated
the LLRs of both the E. coli and GM12878 methylation controls based on the
true states, into groups of methylated calls and unmethylated calls. From the
distributions of these LLRs, we calculated the LLR that would allow 5% false
calls : i.e. top 5th percentile of LLRs for unmethylated calls and bottom 5th
percentile of LLRs for methylated. Then, to make the thresholds symmetric
between methylated and unmethylated calls, we averaged the absolute value
of the two thresholds and applied a ceiling function to the nearest half. As a
result, we chose a threshold of 1.5 for calling CpG methylation (LLR < -1.5 is
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unmethylated, and > 1.5 is methylated, and values between are uncalled) and
a threshold of 1 for GpC methylation. Using these cutoff values on NA12878
testing data, 91% of CpG calls correctly identified methylation at the 72% of
CpGs that pass the threshold and 96% of GpCs calls correctly identified at the
93% that pass the threshold (Figure 2.6a). This is a conservative estimate of
our accuracy because these metrics were calculated with the assumption that
the methylated input was 100% methylated, whereas the bisulfite sequencing
data indicated incomplete ( 96-98%) enzymatic methylation in this testing set.
We then looked at CpG and GpC methylation in all of the testing samples,
and verified that the presence of methylation at a different motif does not
affect the accuracy of the calls for a given methylation motif (Figure 2.6b).
Motif analysis confirmed that the k-mers that had a higher ratio of ambigu-
ously called to correctly called did not have a sequence bias beyond the GCG
motif, which is already excluded from our analysis (Supplementary Figure
2.21). Genome context analysis confirmed that neither the fraction of sites
called nor the fraction of accurate calls was dependent on the genomic context
(Supplementary Table 2.3).
2.3.2 nanoNOMe : Nanopore sequencing of Nucleosome
Occupancy and Methylome
We adapted the NOMe-seq protocol (Kelly et al., 2012) to exogenously label
open chromatin with GpC methylation and apply it to nanopore sequencing,
terming this modified method nanopore sequencing of Nucleosome Occu-
pancy and Methylome (nanoNOMe) (Figure 2.7). The methylation treatment
of intact nuclei results in GpC methylation only at unoccupied, open regions
24
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Figure 2.6: Performance of CpG and GpC dual methylation calling. (a) Fraction of
k-mers passing the threshold filter and the fraction of k-mers from which methylation
was correctly called for a range of thresholds. (b) methylation frequencies for calling
both CpG and GpC methylation in the NA12878 testing samples.
of the genome. Briefly, intact nuclei were extracted from cells by gentle
lysis, followed by methylation with GpC methyltransferase. After purifica-
tion of DNA from these nuclei by phenol:chloroform extraction and ethanol
precipitation, instead of traditional bisulfite conversion, we proceeded to
ligation-based library preparation for nanopore sequencing (ONT). Because
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nanopore sequencing discriminates methylated cytosine residues directly,
bisulfite conversion is unnecessary. However, to preserve the modifications,
we cannot amplify the DNA which necessitates a higher (1-2µg) input amount
of DNA. After sequencing, basecalling, and alignment, we applied our CpG
+ GpC dual methylation model to detect methylation in both CpG and GpC
contexts. Methylation at cytosine residues in GCH contexts was used as a
measure of chromatin accessibility and cytosine residues in HCG contexts as
a measure of endogenous methylation (methylation measurements in GCG
cytosine residues were excluded from analysis). In describing GpCs state, a
methylated GpC was interpreted as an accessible mark, and unmethylated as
inaccessible.
We performed nanoNOMe on a well-characterized GM12878 lymphoblast
cell line (Zook et al., 2016). The advantage of performing nanoNOMe on
GM12878 is threefold : 1) Because GM12878 is one of the most deeply charac-
terized cell line in ENCODE, there are multiple high-quality datasets of epige-
netic assays on GM12878 (ENCODE Project Consortium, 2012). We can use
these datasets to benchmark nanoNOMe and test whether the measurements
from nanoNOMe are comparable to orthogonal techniques. 2) In addition
to assays that probe similar aspects o the epigenome as nanoNOMe, we can
couple the nanoNOMe data with other regulatory datasets on GM12878, such
as RNA-seq and ChIP-seq (ENCODE Project Consortium, 2012), and observe
the association of DNA methylation and chromatin accessibility with other
aspects of genome regulation. 3) Because parent-of-origin single nucleotide
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Figure 2.7: Overview of nanoNOMe Assay. After purifying intact nuclei, sample is
methylated at GpC motifs to serve as the mark for accessibility. CpG methylation and
GpC accessibility can be simultaneously measured via nanopore sequencing.
the reads that originate from parts of the genome with heterozygous SNVs
can be divided into the parent of origin and the allele-specific epigenome can
be studied. We generated 250 Gb (103X coverage) of mapped sequencing data
from 15 flowcells (12 minION and 3 PromethION), with an N50 read length of
14,000 bp. (Table 2.1, Supplementary Table 2.4).
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2.3.3 Comparison of nanoNOMe with conventional
methodologies
To examine the mappability of nanoNOMe and whether the exogenous la-
beling causes any biases in mappability, we compared genomic coverage
of the resulting GM12878 nanoNOMe data to WGBS from a previous study
(100X coverage, ENCODE accession ENCSR890UQO) (ENCODE Project Con-
sortium, 2012) and whole-genome nanopore sequencing of GM12878 (36X
coverage, ENA accession code PRJEB23027) (Jain et al., 2018). One of the
most notorious pitfalls of NGS is the bias of coverage based on the percentage
of Guanine and Cytosine residues (GC content) in the reference sequence
(Olova et al., 2018; Ji et al., 2014). We divided non-ambiguous portions of the
human reference sequence into 200 bp bins and calculated the GC content
of each bin along with the number of reads that were mapped to the bin
in each of the datasets (Figure 2.8). Whereas WGBS coverage was biased
by GC content of the reference sequence bin and increased with increasing
GC content, nanoNOMe and nanopore WGS both showed consistent cover-
















GM12878 12 + 3 PIon* 32.0 298.3 26.4 256.9 103 14,020
MCF-10A 9 9.4 81.6 7.7 72.4 27 11,501
MCF-7 11 9.0 76.8 7.5 69.1 26 13,025
MDA-MB-231 9 8.0 82.4 7.0 74.9 28 13,507
* PromethION flowcell (all other were MinION)
Table 2.1: Sequencing metrics of nanoNOMe sequencing data. NanoNOMe was
performed on four cell lines using multiple runs of MinION, GridION, or PromethION
sequencing and pooled to generate one data set per cell line.
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of coverages irrespective of the GC content and compared to Poisson distri-
bution estimates using means of the coverages (Figure 2.9). When reads are
distributed randomly across the genome, the coverage follows a Poisson dis-
tribution (Lander and Waterman, 1988). We observed that while nanoNOMe
and nanopore WGS coverages closely line up with their respective Poisson
distribution estimates, the distribution of WGBS coverages were wider than its
Poisson estimate (Standard Errors: WGBS=1.26, nanoNOME=0.16, Nanopore
WGS=0.16) , indicating that the coverage is more variable in WGBS.
nanoNOMe WGBS Nanopore WGS

















log10(y) = −0.04e−2 * x + 2 log10(y) = −1.51e−2 * x + 2.6 log10(y) = −0.1e−2 * x + 1.6
Figure 2.8: GC-content bias of coverage in sequencing methods. Binned coverage
versus GC percentage in corresponding bins of nanoNOMe, WGBS (ENCODE), and
WGS by nanopore sequencing, along with regression models representing the degree
of dependence of coverage on GC-content in the form of the slope of the regression
model.
We then examined regions that are poorly mappable via short reads. We
focused on regions that had 10 or more reads with mapping quality (MAPQ)
less than 5, based on bowtie2 alignments in the bismark pipeline, to determine
regions that have low mappability in WGBS. These regions covered 132 Mb of
the human genome, consisting of 57,982 distinct regions with an average size
of 2.3 kb. The coverage of high quality reads (MAPQ > 20) for nanoNOMe
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was between the 5th and 95th percentile of genome coverage (between 67X
and 116X) for 44% of these regions with median coverage of 114X, in contrast
to only 7% in WGBS (between 23X and 168X) with an abnormally high median
coverage of 582X compared to the overall median coverage of 100X. This
demonstrates that long read sequencing, and specifically nanoNOMe, does
not suffer from mismapping of reads to poorly mappable regions and is able
to cover these regions of poor mappability. As a second metric, we examined
genomic contexts known to be difficult to map: CpG islands, repetitive ele-
ments (SINE, LINE, LTR), and satellite regions. For each genomic context, we
identified regions that had coverages between the 5th and 95th percentile of
genome coverage. We observed that nanoNOMe had higher fractions of such
regions for all five genomic contexts, especially LINE and CGI, demonstrating
that nanoNOMe is more robust in aligning to low complexity regions and
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Figure 2.9: Distributions of genome-wide sequencing coverages. Density distribu-
tions of binned coverages show heavy GC bias and deviation from Poisson distribu-
tion in WGBS but not in either of the nanopore-based data.
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We next assessed the performance of nanoNOMe in resolving endogenous
cytosine methylation and chromatin accessibility. On each CpG site in the
human reference sequence that had data in both WGBS and nanoNOMe, we
calculated the frequency of methylation and performed a pairwise comparison
of the frequencies from the two methods (Figure 2.11a). The two datasets had
a high correlation across the genome (Pearson correlation of 0.92), validat-
ing that the endogenous CpG methylation signal from nanoNOMe are not
negatively affected by the exogenous labeling. Using the GpC accessibility
frequency, we detected peaks of accessibility across the genome in nanoNOMe
(see Results 2.3.5). We detected a total of 69,305 peaks, and 85% (58,742) of
these peaks overlapped with peaks called by ATAC-seq and/or DNAse-seq
(Figure 2.11b), demonstrating that accessibility signal from nanoNOMe agrees
well with ATAC-seq and DNAse-seq data.
One of the regulatory features that has a clear association with CpG methy-

































Figure 2.10: Fraction of low-complexity regions that were robustly mapped.
Comparison of fraction of low sequence complexity regions between WGBS and
nanoNOMe that had coverage between 5th and 95th percentile of genome coverage.
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(Kelly et al., 2012; Bell and Felsenfeld, 2000). We performed metaplot analysis
on CTCF binding sites to examine the ability of nanoNOMe signals to observe
the patterns of CpG methylation and nucleosome positioning in specific ge-
nomic contexts. Metaplots are plots of aggregated CpG methylation and GpC
accessibility frequencies across the genome with respect to the distance from
the center of a genomic feature. Because the frequencies are averaged across
the genome in the feature of interest, only the patterns that are strongly associ-
ated with the genomic feature will be highlighted in the resulting metaplot.
We generated metaplots of nanoNOMe CpG methylation and GpC accessibil-
ity with respect to CTCF binding sites, and verified the profiles by plotting the
same metaplots using WGBS and MNase-seq data (Figure 2.12, ENCODE ac-
cession ENCSR890UQO and ENCSR000CXP). NanoNOMe metaplots closely
agreed with respective orthogonal metaplots : in CpG methylation, the re-









































Figure 2.11: Comparison of nanoNOMe profiles with WGBS, ATAC-seq, and
DNAse-seq. Validation of NanoNOMe profiles by (a) pair-wise comparison of per-
CpG average methylation from nanoNOMe with WGBS in across the genome, and
(b) intersections of accessibility peaks from nanoNOMe, DNAse-seq, and ATAC-seq.
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accessible. Both epigenetic features show consistent oscillation of the signal
with a width of 172 bp, indicating consistent positioning of mononucleosomes
(Radman-Livaja and Rando, 2010). In addition, nanoNOMe captures the oc-
cupancy due to the CTCF protein binding, shown by the narrow decrease in
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Figure 2.12: Metaplots analysis of CpG methylation and nucleosome positioning
on CTCF binding sites. Aggregated frequency plots of (a) CpG methylation and (b)
GpC accessibility as a function of distance to CTCF binding motifs in nanoNOMe,
WGBS, and MNAse-seq.
2.3.4 Global epigenomic analysis of gene promoters and
repetitive elements
To correlate nanoNOMe signals with chromatin states and gene activity, we
performed metaplot analysis on transcription start sites (TSSs). We gener-
ated metaplots at TSSs with euchromatic (H3K4me3) and heterochromatic
(H3K27me3) histone modifications using existing ChIP-seq data on GM12878
(Figure 2.13a, ENCODE accessions ENCSR057BWO and ENCSR000AKD). As
expected, CpG methylation decreased and GpC accessibility increased at the
TSS in promoters with active H3K4me3 marks, in contrast to the high CpG
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methylation and low accessibility at promoters with repressive H3K27me3
marks. To observe the association of the two epigenetic features with gene
activity, we separated the TSSs based on the expression quartiles of the corre-
sponding gene transcripts, and observed an increase in chromatin accessibility
and decrease in CpG methylation with increasing expression level (Figure
2.13b, ENCODE accessions ENCSR843RJV). We also examined the combina-
tion of the two features at TSSs, i.e. the combinatorial epigenetic states of gene
promoters, in association with expression and found that the active genes are
characterized by high accessibility and low methylation (concordantly active),
and inactive genes are characterized by low accessibility and high methylation
(concordantly inactive) promoter epigenetic states (Figure 2.13c).
We also characterized patterns of methylation and accessibility in repeti-
tive elements in GM12878. We focused on LINE, LTR, Alu, and MIR, which
are the four most abundantly annotated repetitive elements in the human
reference genome. We compared distributions of per-CpG methylation in
the repetitive regions to randomly shuffled regions of same width that do
not overlap with the repetitive elements (Figure 2.14a). Interestingly, only
Alu elements exhibited a difference in the global distribution of methylation,
higher methylation than the rest of the genome, whereas the other elements
did not show a deviation. This was consistent when comparing per-region
average methylation instead of per-CpG methylation Supplementary Figure
2.22). Accessibility in repetitive elements were examined by comparing the
number of accessibility peaks per megabase in these regions compared to the
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number across the genome (Figure 2.14b). Peaks were depleted in all repeti-























































































































Figure 2.13: NanoNOMe frequency analysis at transcription start sites. (a) Meta-
plots of TSS with euchromatin (H3K4me3) and heterochromatin (H3K27me3) histone
modifications within 1 kb of the TSS. (b) Metaplots of TSS divided up into expression
quartiles of the corresponding gene transcripts (Descending order : 1st is highest
and 4th is lowest expressing transcripts). (c) Pairwise scatter plot of average CpG
methylation to GpC accessibility for 400 bp regions around each TSS, colored by the
expression quartiles.
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elements have decreased accessibility across the genome in GM12878.



































Figure 2.14: NanoNOMe frequency analysis in repetitive elements. (a) Distribu-
tion of observed per-CpG site methylation frequency in repetitive elements in com-
parison to random regions across the genome of the same lengths and (b) number of
accessibility peaks per 1Mb of repetitive regions in comparison to the entire genome.
2.3.5 Visualization and differential region detection
For comparison and visualization of bulk methylation and accessibility, esti-
mated profiles of measurements were calculated by fitting locally weighted
generalized linear models across the genome. Previous studies have shown
that DNA methylation is spatial well-correlated over distances less than 1
kb, and locally smoothing increases reproducibility and consistency of the
methylation profile (Eckhardt et al., 2006; Hansen, Langmead, and Irizarry,
2012). For each CpG site, at least 50 nearby CpG sites and sites within 1 kb
of the site were used to estimate the smoothed methylation frequency. GpC
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accessibility profile was smoothed as well, with reduced windows of 100 bp
and at least 10 nearby GpC sites to account for more rapid fluctuations in the
signal in nucleosome free regions.
To find differentially methylated regions (DMRs) between two samples
without replicates, the difference of the smoothed methylation frequencies
between the two samples was calculated for each CpG site (Figure 2.15).
Then, continuous regions with differences greater than 99th percentile of
the per-site differences were selected as candidates for hypermethylation,
and regions with differences less than the 1st percentile were selected as
candidates for hypomethylation. Similarly, for DARs, we performed a one-
sided Fisher’s Exact test on raw counts of methylated and unmethylated calls
on each candidate DMR. P-values were corrected using Benjamini-Hochberg
correction, and regions with adjusted p-values less than 0.01 and widths
greater than 100 bps were determined to be significant DMRs.
To find regions of high accessibility, continuous regions having smoothed
accessibility greater than 99th percentile of the data were first selected (Figure
2.16). The significance of each accessible region was determined by performing
a binomial test of the raw frequency of accessibility, with overall accessibility
frequency as the null probability. The probabilities were corrected for multiple
testing using Benjamini-Hochberg correction, and accessible regions with ad-
justed p-values less than 0.01 and widths greater than 50 bps were determined
to be accessibility peaks. To determine differentially accessible regions (DARs)
between two samples without replicates, we identified accessibility peaks









































Figure 2.15: Detecting differentially methylated regions. (a) Methylation profiles
are separately smoothed using locally weighted smoothing, then (b) the methylation
is compared between two samples and continuous regions of significant differences
are detected with Fisher’s Exact test and Benjamini-Hochberg correction.
we performed a one-sided Fisher’s Exact test on raw counts of accessible
and inaccessible calls. P-values were corrected using Benjamini-Hochberg
correction, and regions with adjusted p-values less than 0.01 were determined
to be significant DARs.
2.3.6 Comparative epigenomic analysis of breast cancer
model
We applied nanoNOMe to measure epigenetic differences between three well-
characterized breast cell lines: MCF-7 (luminal breast carcinoma, ER+/PR+/HER2-
) and MDA-MB-231 (basal breast carcinoma, ER-/PR-/HER2-) as two subtypes
of breast cancer, and MCF-10A (fibrocystic disease) as the normal baseline
(Holliday and Speirs, 2011; Messier et al., 2016). We performed the assay
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Figure 2.16: Detecting differentially accessible regions. (a) Accessibility profiles are
separately smoothed using locally weighted smoothing, then (b) continuous regions
of high accessibility are selected as peaks of accessibility. (c) Differentially accessible
regions are detected by finding peaks that are exclusive to one of the two samples,
and comparing the accessibility frequency in the regions between the two samples
with Fisher’s Exact test and Benjamini-Hochberg correction.
line (Table 2.1, Supplementary Table 2.4). We detected differentially methy-
lated regions (DMRs) and differentially accessible regions (DARs) across the
genome between MCF-10A and the two cancer subtypes (Figure 2.17). Both
of the cancer subtypes had higher numbers of hypomethylated DMRs than
hypermethylated DMRs (1.8-fold for MCF-7 and 7.6-fold for MDA-MB-231)
suggesting global hypomethylation in the cancer subtypes, consistent with
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previous findings that cancer cells are often globally hypomethylated in com-
parison to normal tissues (Figure 2.17a)(Ehrlich, 2009). In addition, though
to a lesser extent than in methylation, more DARs pointed at higher acces-
sibility in cancer cells than in MCF-10A (1.4-fold for MCF-7 and 1.3-fold for
MDA-MB-231)(Figure 2.17b). Combinatorially, only a subset of DMRs and
DARs coincided at the same genomic loci (8191 overlapping regions, 11%
of DMRs and 6% of DARs), but coinciding DMRs and DARs were highly
concordant, with hypermethylation coinciding with a decrease in accessibility
and vice versa (Pearson correlation < -0.9), highlighting the complementary
nature of differential methylation and accessibility (Figure 2.17c). We refer
to these regions of concordance between a DMR and DAR as concordantly
differential regions (CDR). Interestingly, more concordant differential regions
indicated less activity (decreases of accessibility and increase in methylation)
in the cancer subtypes, especially in MCF-7 (2.5-fold for MCF-7 and 1.2-fold
for MDA-MB-231) (Figure 2.17d).
We then examined the genomic contexts of differential epigenetic regions
by calculating the enrichment of DMRs, DARs, and CDRs in a number of
genomic regions that are associated with regulatory functions (Figure 2.18).
We found that CTCF binding regions, and transcription factor (TF) binding
regions to a lesser extent, are highly enriched in all three types of differen-
tial regions in both MCF-7 and MDA-MB-231. In MCF-7, the DARs in these
regulatory regions were more accessible and TF binding regions were more
cncordantly active, indicating a global increase in affinity to regulatory pro-
teins in MCF-7 (Rothenberg, 2014). In MDA-MB-231, more DARs in CTCF
40
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Figure 2.17: Bulk genome-wide differential methylation and accessibility analysis
on breast cancer models. Histograms of the difference between MCF-7/MDA-MB-
231 and MCF-10A (a) methylation in differentially methylated regions and (b) accessi-
bility in differentially accessibility regions. (c) Comparison of average methylation to
average accessibility in regions that have both differential methylation and accessibil-
ity, showing that in regions of significant methylation/accessibility difference, the two
features are strongly epigenetically concordant. (d) Comparisons of the directions of
DMRs, DARs, and concordantly differential regions. Dotted line is the 1:1 ratio.
binding regions were less accessible, more methylated, and less concordantly
active, suggesting a global decrease in CTCF binding in MDA-MB-231 (Bell
and Felsenfeld, 2000). None of the repetitive elements showed an enrichment
of differential epigenetic regions, indicating that there is no difference in global
activity of repetitive elements.
We also leveraged long reads to detect SVs and observe differences in
epigenetic features near the SV breakpoints. Excluding SVs that occurred
commonly between the three cell lines and those < 50 bp, we called a total of
41
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Figure 2.18: Enrichment of differential epigenetic regions in various genomic con-
texts. (a) Enrichment of DMRs, DARs, and concordantly differential regions are
calculated for each genomic context against the abundance across the genome. (b)
The makeup of directions of the differential regions for each of these genomic contexts
presented as fractions, compared to the makeup of the direction across the whole
genome (dotted line).
18,955 SVs across all three breast lines and compared these using SURVIVOR
(Supplementary Table 2.5) (Sedlazeck et al., 2018; Jeffares et al., 2017). We
found that while many of the insertions were homologous to known repetitive
elements (18% of MCF-10A, 30% of MCF-7, and 25% of MDA-MB-231), the
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repetitive sequences were shared among the three, indicating that there is no
difference in repetitive element activities between the three cell lines. Consis-
tent with this finding, we observed no enrichment of differential epigenetic
regions in repetitive elements (Figure 2.18). The majority of the SVs were sin-
gletons (65.9%), and 1,805 SVs occurred in both of the cancer subtypes and not
in MCF10A. While DMRs and DARs were not enriched in regions surrounding
SVs (Figure 2.18), we were able to identify SVs that occurred only on one cell
line and coincide with differential epigenetic states, demonstrating the ability
of nanoNOMe to evaluate the epigenome in and around SVs (Supplementary
Figure 2.23). As an example, we found an insertion on chr6:169,976,00 that
occurred on both MCF-7 and MDA-MB-231 but not in MCF-10A, which also
showed a region 1kb downstream of the insertion that was hypermethylated
and less accessible (Figure 2.19). These changes in the SV-containing cancer
subtypes show that the structural variants in the region may have caused
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Figure 2.19: Epigenetic differences on an insertion only present in MCF-7 and
MDA-MB-231. Methylation and accessibility of individual reads near an insertion
that is present in MCF-7 and MDA-MB-231 but not in MCF-10A, showing changes in
methylation and accessibility downstream of the insertion
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2.4 Discussion
We have leveraged single molecule nanopore sequencing to directly examine
endogenous CpG methylation and chromatin accessibility on long fragments
of DNA. Leveraging long reads, we measured epigenetic states at genomic
elements that were previously difficult to characterize, including repetitive
elements and structural variations. We can also detect structural variations
(SVs) with long reads, which are difficult to detect with short-read sequenc-
ing, and examine the epigenome in and around these SVs. With the ability
to sequence parts of the genome that were previously difficult to sequence
without sequence context-dependent bias, this method will serve as a valuable
tool in furthering the role of DNA methylation and chromatin accessibility in
regulation of genomic elements, or vice versa.
2.5 Methods
2.5.1 Methylation training and testing set generation
Genomic DNA from E. coli K12 MG1655 (ATCC 700926DQ) and NA12878, i.e.
genomic DNA from GM12878 lymphoblast cell line (Coriell Institute), were
first sheared to an average fragment size of 8 kb using Covaris g-tube shearing
device (Covaris Cat. 520079). The fragmented DNA was PCR amplified
to generate unmethylated DNA using the first steps of low input ligation
kit SQK-LWP001 (ONT). Samples were end-repaired, deoxyadenosine(dA)-
tailed, and ligated to amplification adaptors, followed by 11 cycles of PCR
amplification. The resulting unmethylated, sheared DNA was methylated
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with M. SssI (NEB Cat. M0226) for CpG methylation or M. CviPI (NEB Cat.
M0227) for GpC methylation, or both enzymes for CpG+GpC methylation.
Two cycles of 4-hour methylation were performed for each sample, and for
each cycle of treatment the enzyme and methyl donor (S-adenosylmethionine)
were replenished at the 2 hour mark.
2.5.2 Validation of DNA methylation by bisulfite
sequencing
Near-complete methylation in the training samples (E. coli) and testing sam-
ples (GM12878) were validated by performing whole genome bisulfite se-
quencing on the Illumina MiSeq platform. NEBNext Ultra library preparation
kit (NEB Cat. E7370) and Zymo EZ DNA methylation-lightning kit (Zymo Cat.
D5030) were used to generate the bisulfite sequencing libraries. DNA from
each sample was shared to 300 bp fragments using Bioruptor Pico (Diagen-
ode), followed by end-repair and dA-tailing. Methylated universal adaptor
(NEB Cat. E7535) was ligated using the Blunt/TA ligase from the kit. The
adaptor-ligated samples were bisulfite-converted, quenched, and cleaned-up
before PCR amplification with multiplexing primers and uracil-tolerant Taq
polymerase (KAPA HiFi Uracil+ (Roche Cat. KK2801)). The resulting DNA
sequencing library was sequenced on an Illumina MiSeq device using V2
300-cycle chemistry.
2.5.3 Processing of bisulfite sequencing data
The resulting fastq files were preprocessed by removing adaptor sequences
and trimming low quality 3’ ends using Trim Galore version 0.6.3 (https:
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//github.com/FelixKrueger/TrimGalore) with default parameters. Then,
data was analyzed using Bismark version 0.19.0 (Krueger and Andrews, 2011).
After alignment, PCR duplicates were removed using Picard tools MarkDu-
plicates module version 2.20.2 (http://broadinstitute.github.io/picard/).
Reads were truncated at the 3’ end by 2 bases at the 5’ end and 1 base at 3’
end to minimize methylation bias at the ends of reads introduced during
the library preparation. The total number of methylated cytosine residues
and unmethylated cytosine residues were counted to calculate methylation
percentages of the samples.
2.5.4 nanopolish methylation training for dual CpG/GpC
methylation calling
To train the methylation calling models we generated nanopore sequencing
data for E. coli gDNA treated with M.SssI (to methylate CpGs), M.CviPI
(to methylate GpCs), and both M.SssI and M.CviPI (to methylate in both
contexts) (described above). The three datasets were basecalled with Guppy
(version 3.0.3) and aligned to the E. coli genome using NGMLR version 0.2.8.
The reference genomes for each dataset were then modified by converting
Cs to Ms in the appropriate context. We then merged the three reference
genomes and three BAM files together and downsampled the alignments to
10% coverage to reduce model training time in the subsequent step. At the end
of this preprocessing, we had a dataset with a mixture of reads that have CpG
methylation, GpC methylation, or both, and matching reference sequences to
align each read to indicate the pattern of methylation in each read.
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The k-mer states for the CpG/GpC model were trained using âĂIJna-
nopolish trainâĂİ module in nanopolish cpggpc_new_train branch (commit
c409580). Model training was run for 10 iterations and the final model was
used for the subsequent methylation calling.
2.5.5 Cell Culture
GM12878 lymphoblast cells were obtained from Coriell Institute and MCF-
10A, MCF-7, and MDA-MB-231 breast cells were obtained from ATCC. GM12878
were grown in RPMI 1640 medium (Gibco Cat. 11875119) supplemented
with 15% fetal bovine serum (FBS, Gibco Cat. 26140079) and 1% penicillin-
streptomycin (P/S, Gibco Cat. 15140122). MCF-10A were grown in DMEM
F-12 medium (Gibco Cat. 11320033) supplemented with 5% horse serum
(Gibco Cat. 16050122), 10 µg/mL human insulin (Sigma Aldrich Cat. 19278),
20 ng/mL hEGF (Gibco Cat. PHG0311L), 100 ng/mL Cholera toxin (Sigma
Aldrich Cat. C8052), 0.5 µg/mL Hydrocortisone (Sigma Aldrich Cat. H0135),
and 1% P/S. MCF-7 and MDA-MB-231 were grown in DMEM (Gibco Cat.
11965118) supplemented with 10% FBS and 1% P/S.
2.5.6 Nucleosome footprinting via GpC methyltransferase
NOMe-seq was performed on the cells with adjustments for nanopore se-
quencing. Cells were collected by trypsinization, then nuclei were extracted
by incubating in resuspension buffer (100 mM Tris-Cl, pH 7.4, 100 mM NaCl,
30 mM MgCl2) with 0.25 % NP-40 for 5 minutes on ice. Intact nuclei were col-
lected by centrifugation for 5 minutes at 500xg at 4 °C. Nuclei were subjected
to a methylation labeling reaction using a solution of 1x M. CviPI Reaction
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Buffer (NEB), 300 mM sucrose, 96 µM S-adenosylmethionine (SAM; New
England Biolabs, NEB), and 200 U M. CviPI (NEB) in 500 µL volume per
500,000 nuclei. The reaction mixture was incubated at 37 °C with shaking on a
thermomixer at 1,000 rpm for 15 minutes. SAM was replenished at 96 µM at
7.5 minutes into the reaction. The reaction was stopped by the addition of an
equal volume of stop solution (20 mM Tris-Cl, pH 7.9, 600 mM NaCl, 1% SDS,
10 mM disodium EDTA). Samples were treated with proteinase K (NEB) at 55
°C for > 2 hours, and DNA was extracted via phenol:chloroform extraction
and ethanol precipitation. After proteinase K treatment, and in all following
steps, samples were handled with care using large orifice pipette tips to avoid
excessive fragmentation of DNA.
2.5.7 Nanopore sequencing
Purified gDNA was prepared for nanopore sequencing following the proto-
col in the genomic sequencing by ligation kit LSK-SQK108 (ONT). Samples
were first sheared to 10 kb using G-tubes (Covaris): by centrifuging 2-3µg
of unfragmented gDNA at 5,000X G for 1 minute, then inverting the tube
and centrifuging again. We sheared the DNA to 10 kb because it produces
long fragments of DNA while maximizing the yield of nanopore sequencing.
Shearing to larger sizes or unsheared DNA may be used to maximize the
length of sequenced reads, with the caveat that sequencing yield will drop. In
two samples (GM12878 samples 8 and 9), we targeted 20kb fragments, with an
additional step of removing short fragments using the Short Read Eliminator
module by Circulomics, following the manufacturerâĂŹs specifications. The
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sheared samples were end-repaired and dA-tailed using NEBnext Ultra II end-
repair module (NEB), followed by clean-up using 1X v/v AMPure XP beads
(Beckman Coulter). Sequencing adaptors, comprised of leader adaptor DNA
and motor proteins, were ligated to the end-prepared DNA fragments using
Blunt/TA Ligase Master Mix (NEB), followed by clean-up using 0.4X v/v
AMPure XP beads and sequencing kit reagents. >400 ng of adaptor ligated
samples per flow cell were loaded onto FLO-MIN106 or PRO-002 flowcells
and run on MinION Mk1b, GridION, or PromethION sequencers for up to 72
hours.
2.5.8 Data Processing (basecalling, alignment, and structural
variant calling)
Raw current signals were converted to DNA sequences using Guppy version
3.0.3 (ONT), using the “high-accuracy” basecalling model (Jain et al., 2018).
DNA sequences were aligned to hg38 human reference genome without alter-
native contigs using NGMLR version 0.2.8 with default settings for aligning
Oxford nanopore reads (-x ont) (Sedlazeck et al., 2018). We used Sniffles
version 1.0.11 (Sedlazeck et al., 2018) with default parameters to detect SVs
across each sample and SURVIVOR version 1.0.734 to obtain a multi-sample
VCF file.
2.5.9 Nanopolish methylation calling for dual CpG/GpC
methylation
We modified the methylation calling module of nanopolish to be able to call
methylation in multiple motifs simultaneously (github branch cpggpc_new_train,
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commit c409580). As in our previous work, we start by grouping nearby CpG
and GpC sites together (minimum distance of 5 to separate sites). We then
calculate a likelihood for combinations of the grouped sites being methylated
or unmethylated (either no sites methylated, all CpGs methylated, all GpCs
methylated, or all sites both contexts methylated), using the k-mer states
trained in the previous section, with the hidden Markov model we previ-
ously described. We then calculate a log-likelihood ratio for each motif (CpG,
GpC), by summing the likelihoods across all sequences where the motif is
methylated, or unmethylated.
2.5.10 Comparison of nanoNOMe with conventional
methodologies
Bulk NGS methodologies comparable to nanoNOMe on GM12878 were used
to compare and validate nanoNOMe. Whole genome bisulfite sequencing
methylation frequencies were obtained from Encode accession ENCFF835NTC,
normalized MNase-seq signals were obtained from Encode accession ENCSR000CXP,
and normalized DNAse-seq signals were obtained from Encode accession
ENCSR000EJD (ENCODE Project Consortium, 2012). ATAC-seq data was
obtained from GEO accession GSE47753 and processed using the standard
ENCODE pipeline (Buenrostro et al., 2013; ENCODE Project Consortium,
2012). Nanopore whole genome sequencing data was obtained from ENA
accession PRJEB23027, and processed the same way as nanoNOMe (Jain et al.,
2018).
For comparing mappability between WGBS, nanopore WGS, and nanoNOMe,
the numbers of reads aligning to 200 bp bins of the genome were calculated.
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GC-bias of the coverages were determined by calculating the percentages of
C/G for each of the 200 bp bins and plotting the per-bin coverage against
the CG percentage. To compare mappability in specific genomic contexts, a
region was considered to be robustly mapped in a dataset if its coverage was
between the 5th and 95th percentile of the genome-wide binned coverage. The
upper threshold takes into account aberrantly highly mapped regions, while
the lower threshold removes low mappability regions.
For comparison of nanoNOMe signals with conventional bulk methods,
average methylation was calculated for each CpG and GpC site. To compare
nanoNOMe CpG methylation to WGBS methylation, methylation frequencies
for each CpG locus across the genome were compared pairwise between the
two methods. To compare nanoNOMe GpC accessibility signal to normalized
ATAC-seq and DNAse-seq signals, the intersections were determined from
accessibility peaks of nanoNOMe, ATAC-seq, and DNAse-seq.
2.5.11 Metaplot Analysis
Methylation frequencies from WGBS and normalized MNase-seq signals at
regions surrounding genomic features of interest (CTCF, TSS with respect
to expression and histone modifications) were extracted for the generation
of the metaplots. For each genomic feature, average methylation frequency
and accessibility were aggregated with respect to distance from the feature,
followed by taking the rolling average with a window of 50 bp. Known
TSS and CGI were obtained from Gencode (release v29). TSSs were grouped
by expression quartile based on RNA-seq of GM12878 (ENCODE accession
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ENCSR843RJV), and by the presence of ChIP-seq peaks of histone modi-
fications H3K4me3 (ENCODE accession ENCSR057BWO) and H3K27me3
(ENCODE accession ENCSR000AKD) within 1kb of the TSS. CTCF binding
sites were determined by overlapping computationally predicted CTCF bind-
ing sites with conservative IDR peaks in ChIP-seq of CTCF on GM12878
(ENCODE accession ENCSR000AKB) and removing peaks that fell within 2kb
of known TSS (Ziebarth, Bhattacharya, and Cui, 2013).
2.5.12 Enrichment analysis of differential epigenetic regions
on genomic contexts
To calculate the enrichment of DMRs, DARs, and concordantly differential
regions in various genomic contexts, we first calculated the total width of the
genome and the total width of the genomic contexts of interest that contain
CpG and GpC data. Then the total number of differential regions was divided
by the total width of the genome, which is the expected abundance of dif-
ferential regions. This was used as the baseline against the total numbers of
differential regions in genomic contexts of interest divided by the total widths
of the genomic contexts to generate the final values of enrichment. For TSS
and small TF binding sites, we used 1000 bp regions centered on the genomic
elements.
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2.7 Supplementary Material
Sample Methyla�on Total Reads
Reads with 
MAPQ >= 20 Frac�on Yield (Gb) Coverage
E. coli Unmethylated 724,887 707,199 0.98 4.14 891.24
E. coli CpG 1,396,674 1,355,969 0.97 7.39 1592.70
E. coli GpC 1,251,301 1,209,030 0.97 7.15 1540.85
E. coli CpGGpC 1,084,568 1,048,904 0.97 6.41 1381.27
NA12878 Unmethylated 2,999,723 2,803,707 0.93 10.28 3.18
NA12878 CpG 2,951,563 2,748,099 0.93 8.47 2.62
NA12878 GpC 2,941,260 2,723,240 0.93 9.28 2.87
NA12878 CpGGpC 2,848,032 2,631,771 0.92 9.14 2.83
Table 2.2: Nanopore sequencing yields of testing and training samples. After se-
quencing the training and testing sets on a minION nanopore sequencing, total
numbers of methylated loci and unmethylated loci for each sample was tabulated to
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Figure 2.20: Distributions of current modulation in select 6-mers.
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Table 2.3: Relative accuracy and call rates for notable genomic contexts. Accuracy
and call rate with respect to genomic contexts in comparison to overall accuracy and
call rate (context accuracy/call rate divided by overall accuracy/call rate). A relative
value of 1 represents the same value in the context in comparison to overall value; No
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Figure 2.21: Sequence context dependence of methylation calling accuracy. (a) The
ratio of ambiguous and incorrectly called calls to correctly called calls for every 6-mer
with the methylation motif in the center (3th position for CpG and 4th position for
GpC), and (b) motif analysis of enriched ambiguous 6-mers from (d) in (left) CpG
calls and (right) GpC calls, showing enrichment in GCG motifs in GC calling, which














bases (Gb) N50 length
GM12878 1 FLO-MIN106 2 1.64 12.95 1.30 11.20 11,475
GM12878 2 FLO-MIN106 2 1.90 14.86 1.56 12.68 10,736
GM12878 3 FLO-MIN106 2 0.81 6.53 0.68 5.66 10,526
GM12878 4 FLO-MIN106 2 1.03 11.10 0.89 9.79 17,346
GM12878 5 FLO-MIN106 2 1.95 14.77 1.55 12.11 11,635
GM12878 6 FLO-MIN106 2 2.09 15.42 1.69 13.55 11,156
GM12878 7 FLO-PROM002 1 11.51 72.84 8.90 62.62 9,791
GM12878 8 FLO-PROM002 1 5.40 85.51 4.80 74.94 20,850
GM12878 9 FLO-PROM002 1 5.66 64.28 5.03 54.37 20,626
MCF10A 1 FLO-MIN106 2 0.86 6.52 0.60 5.70 11,428
MCF10A 2 FLO-MIN106 3 3.59 33.11 3.05 29.64 11,888
MCF10A 3 FLO-MIN106 4 4.96 41.96 4.09 37.06 11,215
MCF7 1 FLO-MIN106 1 1.17 9.71 1.03 8.77 11,210
MCF7 2 FLO-MIN106 2 0.78 5.29 0.52 4.72 11,652
MCF7 3 FLO-MIN106 5 5.42 44.25 4.48 39.61 12,462
MCF7 4 FLO-MIN106 3 1.62 17.51 1.46 16.05 18,532
MDAMB231 1 FLO-MIN106 1 0.89 8.22 0.78 7.39 11,531
MDAMB231 2 FLO-MIN106 2 2.10 19.01 1.82 17.30 11,488
MDAMB231 3 FLO-MIN106 3 3.09 33.06 2.68 30.14 14,583
MDAMB231 4 FLO-MIN106 3 1.87 22.10 1.67 20.06 15,783
Table 2.4: Individual nanopore sequencing run metrics of nanoNOMe samples.
Nanopore sequencing run statistics for individual sequencing experiments performed,
















Figure 2.22: Per-Region nanoNOMe frequency in repetitive elements. Distribution
of observed per-region average methylation frequency in repetitive elements in
comparison to random regions across the genome of the same lengths.
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Sample DEL INS DUP INV TRA Total
MCF10A  2245 1381 188 37 57 3908
MCF7 2297 1139 225 63 110 3834
MDAMB231 2605 1754 305 44 37 4745
MCF7 + MDAMB231 1020 669 92 9 15 1805
MCF10A + MDAMB231 1562 1124 156 14 11 2867
MCF10A + MCF7 1032 655 69 19 21 1796
Total 10761 6722 1035 186 251 18955
Inclusive counts
MCF10A 4839 3160 413 70 89 8571
MCF7 4349 2463 386 91 146 7435
MDAMB231 5187 3547 553 67 63 9417
Table 2.5: Summary of structural variations detected in breast cell lines. Structural
variations types are deletions (DEL), translocations (TRA), duplications (DUP), inver-
sions (INV), and insertions (INS), and are grouped by uniquely occurring (first three
lines), commonly occurring in any combination of two cell lines (second three lines),
and a summary of inclusive counts for each cell line. SVs of < 50bp were filtered out.
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DEL in MCF−7, MDA−MB−231
Figure 2.23: Structural variations and differential epigenetics. Single-read methy-
lation and accessibility plots of regions that had an SV in the cancer subtypes and
not in MCF-10A, as well as differential methylation and accessibility in the cancer
subtypes in comparison to MCF-10A.
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We have shown the use of nanopore sequencing for studying the endogenous
CpG methylation and exogenously labeled chromatin accessibility (nanoNOMe).
In addition to the bulk analysis, there are several ways to utilize the long reads
of nanopore sequencing. The long single-molecule resolution allows foot-
printing of protein and nucleosome binding, allowing the separation of reads
based on protein binding state. On gene promoters, combinatorial epigenetic
states can be measured on individual molecules. The long reads also make
it possible to robustly assign reads to haplotypes, separating the data into
maternal and paternal alleles. This also separates the methylation and accessi-
bility information embedded in the reads, allowing allele-specific epigenetic
analysis across the genome. We use existing SNV data on GM12878 to phase
the nanoNOMe reads and present the first fully phased human epigenome,




Previous studies have demonstrated that nucleosome positioning and DNA
accessibility are heterogeneous even within a homogeneous cell population,
highlighting the importance of probing these features on individual copies of
the DNA (Buenrostro et al., 2015; Lai et al., 2018). This becomes even more
important when the cell population is heterogeneous, such as in primary tis-
sues or blood samples. This has led to adaptation of chromatin profiling and
epigenetic assays to single-cell approaches (Guo et al., 2013; Smallwood et al.,
2014; Clark et al., 2018; Lai and Pugh, 2017; Satpathy et al., 2019). Single-cell
adaptations of bisulfite sequencing assays have characterized the heterogene-
ity of CpG methylation in embryonic stem cells and conversely the consis-
tency of CpG methylation in haploid cells (Guo et al., 2013; Smallwood et al.,
2014). Single-cell MNase-seq revealed that heterochromatic regions have large
variation in nucleosome positioning while the nucleosomes are uniformly
positioned, and euchromatic regions have lower variation of nucleosome po-
sitioning with inconsistent spacing especially at the hyperaccessible regions
(Lai and Pugh, 2017). Application of single-cell ATAC-seq on tumor biopsies
has identified a subset of cells that show response to anti-tumor treatments,
demonstrating the potential of using single-cell approaches to detect subtle
changes in response to stimuli (Satpathy et al., 2019). More recently, single-cell
adaptation of NOMe-seq was coupled to single-cell RNA-seq, presenting mea-
surements of multiple layers of gene regulation on single-cell resolution (Clark
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et al., 2018). Nanopore sequencing is similar to these single-cell sequencing
methodologies: the long reads can be utilized to link epigenetic patterns across
long distances on individual reads, making the observations of these patterns
on single-molecule resolution.
Normal somatic mammalian cells are diploid, meaning each cell carries
two copies of each chromosome in the nucleus, one set (i.e. allele) from each
parent. The function of epigenetics has been widely implicated in allele-
specific activity of chromosomes, and it is well known that CpG methylation
plays a pivotal role in X chromosome inactivation (Han, Lee, and Szabó, 2008;
Fournier et al., 2002; Singer-Sam and Riggs, 1993). However, this difference in
epigenetic signatures between alleles is problematic in NGS methodologies
because the signal from one allele can reduce the signal from the other allele,
and separating the alleles is not a trivial task, even in single-cell sequencing
methodologies. This problem of ploidy becomes even more confounding in
cases of aneuoploidy, where a cell has abnormally large number of chromo-
somes, which is widely prevalent in all types of cancers (Lengauer, Kinzler,
and Vogelstein, 1998).
One way to resolve the parent-of-origin of DNA is by annotating single
nucleotide variations (SNVs) in a parental trio : in an individual and both
of his or her parents (1000 Genomes Project Consortium et al., 2010). By
tracing heterozygous mutations from the individual to mutations present in
the parents, the parental origin of the mutation can be deduced. Studies have
used these haplotype annotations to phase DNA and RNA sequences and
resolve allele-specific genomes and transcriptomes (Rozowsky et al., 2011;
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Bansal and Bafna, 2008). However, to phase the DNA strands to an allele, a
heterozygous SNV must be present within the read. Because of this, phasing
NGS reads is limited to regions with high density of heterozygous SNVs.
Nanopore sequencing, on the other hand, generates long reads, so each read
has a greater chance of encountering one or more heterozygous SNPs which
can be used to phase the reads into maternal or paternal origin.
Here we show the application of nanoNOMe in 1) observing chromatin
accessibility and CpG methylation patterns on single-read resolution and
2) phasing the reads into their parental alleles, generating a first genome-
wide map of allele-specific CpG methylation and chromatin accessibility on a
human genome.
3.3 Results
3.3.1 Co-occurrence of accessibility patterns to observe
cis-regulatory interactions
We explored the applicability of long reads generated from nanoNOMe in
detecting patterns of the epigenetic features. Using the epigenetic features
encoded on long sequences of reads, we can observe patterns of these fea-
tures along the length of the reads, e.g. positioning of multiple nucleosomes
on single strands of DNA by oscillation of GpC methylation. However, the
inherent heterogeneity of the chromatin due to the dynamic nature of nucle-
osome positioning is directly translated to the single-read data, making it
difficult to observe patterns of epigenetic features (Lai and Pugh, 2017). The
biological heterogeneity of DNA accessibility is further compounded by errors
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associated with the enzymatic methylation, such as imperfect methylation
efficacy, non-specific methylation, and dissociation of nucleosomes in a small
fraction of DNA during lysis. In order to resolve patterns of methylation
and DNA accessibility on single-read resolution, we have to account for the
heterogeneity and noise.
To that end, we focused on co-occurrences of methylated or unmethylated
cytosine on each read, where the co-occurrence is defined by same type of
event (methylated or unmethylated) being observed at two distinct positions
on a given read (see Methods 3.5.1). Piling up the co-occurrence across reads
in a given region, we found that patterns of read-level nucleosome positioning
across the length of reads can be resolved using a co-occurrence matrix (Figure
3.1). Because this analysis measures the relationships of methylation - in the
case of methylated co-occurrence - and unmethylation - i nthe case of un-
methylated co-occurrence - between positions on individual reads, the peaks
in the heatmap highlight locations of co-occurring nucleosome positioning
and distances between them, whereas the average plot only indicates that
nucleosomes were present without any relationship to other locations.
3.3.2 Improving single-molecule accessibility measurements
using a smoothing estimator
Though the co-occurrence matrices have the ability to show patterns of acces-
sibility that bulk measurements cannot, the method still relies on aggregation
of the measurements to identify hotspots of interactions. So this is not a
true single-molecule analysis, and will be unable to resolve interactions that
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Figure 3.1: Matrix of accessibility co-occurrence on individual reads. Co-
occurrence of accessibility and inaccessibility (GpC) are observed across the lengths of
single reads and the co-occurrences events are piled up across all reads in the region
resolves patterns such as co-associated nucleosome occupancy.
embedded on individual long strands of reads, we turned to direct ways to
remove the noise in the single-read measurements of GpC accessibility. In the
control testing samples, we examined the patterns of incorrect accessibility
calls and found that 75% of incorrect calls were singletons, surrounded by
correct calls, meaning that most of the noise is isolated. To remove the isolated
noise, we implemented a method to estimate the accessibility of a given site
using information from nearby GpC motifs on the same molecule, thereby
dampening the isolated erroneous signal (see Methods 3.5.2). Briefly, we
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applied a Gaussian kernel regression on the LLRs of accessibility calls using
fixed genomic coordinate bandwidths and estimated accessibility across indi-
vidual reads. We smoothed the GM12878 nanoNOMe data at CTCF binding
sites, where accessibility profiles are the most consistent. We verified that the
smoothing reduces the frequency of artifactual spikes in accessibility, evident
by the removal of the very short lengths in the distribution plot of accessible
and inaccessible runs (a run refers to a consecutive sequence of the same
accessibility call) (Figure 3.2a). Aggregated frequencies of the smoothed calls
still retained the oscillatory pattern, showing that the smoothing does not
significanly decrease the ability to footprint nucleosome positioning (Figure
3.2b). Lastly, the smoothed calls allowed easier visualization of the patterns
of accessibility on single-read level (Figure 3.2c).
3.3.3 Resolving regulatory protein binding on individual
reads
We proceeded to characterize patterns of accessibility and methylation at
CTCF binding sites on individual reads. First, we selected reads that span
2kb regions centered on 1,000 randomly selected CTCF binding sites from
the 6,793 CTCF-binding sites with a ChIP-seq peak and another 1,000 from
4,288 binding sites without a ChIP-seq peak and examined runs of open and
closed accessibility calls (Figure 3.3) (Ziebarth, Bhattacharya, and Cui, 2013;
ENCODE Project Consortium, 2012). The position of closed runs differed
between bound sites (sites with CTCF ChIP-seq peaks) and unbound sites
(without peaks), with bound sites having a consistent pattern of nucleosome
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Figure 3.2: GpC accessibility kernel estimation on single reads. GpC methylation
calls were smoothed using a Gaussian kernel estimator. (a) Distributions of length of
open and closed runs and (b) metaplot of accessibility near CTCF binding sites before
and after the smoothing, along with (c) example of read-level plot of accessibility
from a 2kb region around a CTCF binding site.
nucleosomes, shown by hotspots of closed runs at 128 bp (mononucleosomes)
and 310bp (dinucleosomes). Examining the length of the closed runs at the
center of CTCF binding sites, we found a higher occurrence of shorter runs
(<80bp), suggesting CTCF binding (Supplementary Figure 3.17a). This short
length of inaccessibility by regulatory protein binding is consistent with pre-
vious findings of protein-DNA interactions via DNAse hypersensitivity and
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Figure 3.3: Single-molecule accessibility at CTCF binding regions. Heatmaps of
lengths of (a) closed accessibility runs and (a) open accessibility runs on individual
reads versus distance from CTCF binding sites, showing the relationship between
accessibility run lengths and protein/nucleosome binding and the difference of these
patterns on binding sites with and without ChIP-seq peaks.
Based on these observations, we used the length of closed runs at CTCF
binding sites to infer CTCF binding state on individual reads (Supplementary
Figure 3.17b, see Methods 3.5.3). We then separated reads based on their
CTCF binding status and calculated the fraction of CTCF-bound reads for each
site (Figure 3.4). Because nanoNOMe does not rely on enrichment or PCR to
detect accessibility, the fraction of CTCF-bound reads represents a quantitative
estimate of the degree of CTCF binding at the given site. We compared this
data with CTCF Chip-seq peaks and found that the fraction of CTCF-bound
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reads increased with increasing enrichment in ChIP-seq (Pearson correlation of
0.49), as opposed to sites outside of peaks that have consistently low fractions
of CTCF-bound reads (median fraction of 0.02, Figure 3.5). Furthermore, we
found the fraction of CTCF-bound reads varies widely even at places with
ChIP-seq peaks.
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Figure 3.4: Per-read plot of methylation and accessibility on a CTCF binding site.
CpG methylation and GpC accessibility of individual reads on a CTCF binding site,
grouped by the predicted protein-binding state at the CTCF binding site.
To examine the global association of the affinity of the region to CTCF
(presence of ChIP-seq peak) and the actual state of protein binding (read-level
protein-binding prediction), we stratified the reads on CTCF binding sites
based on the two layers of information : 1) whether the region had a peak in
CTCF ChIP-seq and 2) whether we predicted the read to have protein binding
at the binding site. We then generated methylation and accessibility metaplots
of the aggregated profiles in each group (Figure 3.6). We found that reads on
bound sites have consistently lower methylation even on reads that were not





































Figure 3.5: Comparison of protein-binding predictions with ChIP-seq signals. The
read-level CTCF binding classification was tested by (a) comparing the per-site CTCF-
bound read fractions with ChIP-seq coverage enrichment, showing that the ChIP-seq
signal tends to increase with CTCF binding fraction, and (b) comparing the fractions
in binding sites with ChIP-seq peaks to those without peaks, showing that sites with
ChIP-seq peaks have higher fractions of CTCF binding.
CTCF binding sites increases the affinity of the protein to the binding site21.
Similarly, we observed that nucleosomes are well-positioned irrespective of
current CTCF occupancy.
3.3.4 Single-molecule combinatorial promoter epigenetic
states
Next, we investigated epigenetic patterns on transcription start sites with
single-read resolution on 1,000 randomly sampled genes from each expression
quartile. On the TSS of highly transcribed genes, we observed a well-organized
pattern of nucleosome positioning (low accessibility regions) and longer open
runs representing nucleosome depleted regions (NDRs), whereas no pattern
could be observed in lowly transcribed genes (Figure 3.7a). With decreasing
expression, methylation increased and accessibility decreased around TSS (1kb
for CpG and 200 bp for GpC) on a single-read level, in line with observations
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Figure 3.6: Metaplots of CTCF binding sites stratified by ChIP-seq peak and read-
level protein binding. Metaplots at CTCF binding sites, separated by the presence
of CTCF ChIP-seq peaks by panel and read-level CTCF binding by color, showing
consistent epigenetic patterns on bound sites regardless of read-level binding state.
around the TSS to categorize reads into two groups (high and low frequency)
for each feature (Figure 3.7c, see Methods 3.5.4). Mean CpG methylations
for the two groups were 3% (demethylated) and 62% (methylated), and GpC
groups had mean accessibilities of 20% (inaccessible) and 90% (accessible).
Combining the two features resulted in four possible combinatorial epi-
genetic states for each read (Figure 3.8). We observed that with increasing
expression, fractions of concordantly active reads (low CpG methylation and
high accessibility) increase and concordantly inactive (high CpG methylation
and low accessibility) reads decrease (Supplementary Figure 3.18a). We also
found that genes with euchromatic H3K4me3 histone modification within
1kb of the TSS have low CpG methylation, and genes with heterochromatic
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Figure 3.7: Single-read epigenetic assessment on transcription start sites. (a)
Heatmaps of lengths of closed and open accessibility runs on individual reads with
respect to the distance to transcription start sites, showing the difference in accessibil-
ity patterns in highly expressed and lowly expressed gene TSS. (b) Distributions of
per-read CpG methylation frequency in 1kb region around TSS and GpC accessibility
frequency in 200 bp region around TSS, stratified by expression, showing that more
reads are demethylated and accessible with an increase in expression. (c) We used
the windows in (b) to cluster the reads based on methylation around TSS into two
groups for each feature, high frequency (blue) and low frequency (red), resulting in
four possible combinatorial states for each read at TSS.
H3K27me3 modification mostly have inaccessible reads (Supplementary Fig-
ure 3.18b). Further, the majority of reads on promoter regions with bivalent
histone modifications (both H3K4me3 and H3K27me3) have both low CpG
methylation and low accessibility, combining the pattern of CpG methylation
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Figure 3.8: Clustering reads based on promoter combinatorial epigenetic state.
Reads on TSS can be a classified based on the combinatorial epigenetic states near
TSS, b stratified based on these classifications. c Using the long reads, methylation
and accessibility frequency profiles can be obtained from each group of combinatorial
epigenetic states extending further out from the TSS
3.3.5 Protein binding in association with promoter
epigenetic state
We then coupled our ability to probe protein binding and determine combi-
natorial promoter epigenetic states to identify protein binding events asso-
ciated with specific promoter states. Using the same subset of genes from
the single-read promoter analysis, we examined protein-binding sites within
10kb upstream and downstream of the TSS. We predicted protein binding
state on all closed accessibility runs, and selected regions that have multiple
overlapping instances of protein binding as candidate sites for protein bind-
ing (regions having >= 10 overlapping instances estimated protein-binding
states, (see Methods 3.5.5). We then performed motif enrichment analysis
using Haystack against the JASPAR transcription factor database to determine
enrichment values, if any, of these candidate regions in transcription factor
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binding sites (Supplementary Figure 3.19) (Pinello, Farouni, and Yuan, 2018;
Fornes et al., 2020). Several TFs were enriched in the candidate regions, in-
cluding CTCF, NRF1, and Zinc finger proteins, with the strongest enrichment
in CTCF binding sites having a 4x observed/expected ratio. We then stratified
the reads based on promoter epigenetic state and calculated the fraction of
protein-bound reads in each cluster of combinatorial epigenetic state. In gen-
eral, groups of reads which had an accessible promoter had a higher fraction
of protein-bound reads than inaccessible groups, showing that our protein
binding analysis captures protein binding events that are associated with
active promoter state (Figure 3.9).
For a specific example, we examined PIM2, a gene that facilitates cell
survival and proliferation and is highly expressed in GM12878 (1st quartile).
PIM2 has a closed run-predicted protein binding site 1.5kb downstream of the
TSS present only in the reads with an epigenetically active promoter (Figure
3.10). We identified a CTCF binding motif in this region and confirmed it had
a peak in existing CTCF ChIP-seq data. This directly links CTCF binding on
the same molecule as an accessible promoter 1.5kb away.
We then interrogated individual reads in promoter regions of the breast
cancer cells. On promoters of differentially expressed genes in MCF-7/MDA-
MB-231 in comparison to MCF-10A, we estimated protein binding and de-
termined single-read promoter epigenetic states. One such gene, ZNF714,
is a protein-coding gene for the zinc finger protein 714 and is upregulated
in MCF-7 and MDA-MB-231. Two groups of combinatorial epigenetic states
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Figure 3.9: Comparisons of predicted TF-binding with respect to promoter epige-
netic states. For each of the 1,000 randomly selected genes, protein-binding regions
were predicted within 10kb of the TSS. Reads were then split into two groups based
on their epigenetic state: (left) CpG methylation, (center) accessibility (right) con-
cordance of both, and the fraction of protein-occupied reads was calculated. The
relationship between protein-binding and promoter epigenetic state is assessed by a
the distribution of fractions of protein-bound reads between read groups, and b the
difference between the two groups for each region.
accessible) and inactive (methylated and inaccessible) (Figure 3.11). The two
cancer subtypes have more of the reads in the active state, suggesting that
there are more epigenetically active copies of the gene in the cancer subtypes.
In addition, the active reads in the cancer subtypes have short closed runs at
the same region, suggesting protein binding in these copies, while the active
reads in MCF-10A do not. These observations collectively suggest that the up-
regulation of ZNF714 occurs in conjunction with increased epigenetic activity
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Figure 3.10: Per-read plot of methylation and accessibility on a gene promoter with
protein binding. Read-level plots of methylation and accessibility on the promoter of
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Figure 3.11: Read-level comparative epigenomic analysis of breast cancer model.
Read-level methylation and accessibility plots on the TSS of ZNF714 gene, which is
upregulated in MCF-7 and MDA-MB-231 in comparison to MCF-10A, showing the
differences in the estimated protein binding and combinatorial epigenetic states.
3.3.6 Allele-specific methylation and chromatin accessibility
in X chromosome inactivation
Using existing variant data on GM12878 and both parents, we selected het-
erozygous SNPs and assigned haplotype origin to individual nanoNOMe
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reads (Eberle et al., 2016). We were able to confidently determine haplotype
assignments on 65% of our sequencing reads across all chromosomes, divided
equally to the two haplotypes (paternal: maternal ratios between 0.96 and
1.02), and the phased reads covered 86% of the genome to at least 10x coverage
on both alleles (Figure 3.12). Having separated the reads based on the parent
of origin, we could separate the epigenetic signal within each read into the
two alleles as well, therefore generating the first genome-wide allele-specific
profiles of DNA methylation and accessibility on a human genome, using a
single assay.
We looked into X chromosome inactivation to validate the allele-specific
epigenetic profiles. We compared methylation and accessibility near TSSs of
autosomal genes, X-chromosome inactivated (XCI) genes, and X-chromosome
genes that are known to escape XCI (hereafter referred to as escape genes) via
metaplot analysis (Figure 3.13a) (Tukiainen et al., 2017). Genes on the active X
chromosome (Xa; maternal allele) were concordantly active with demethylated
and accessible promoters and those of inactive X chromosome (Xi; paternal
allele) were concordantly inactive with methylated and inaccessible promoters,
whereas in autosomal genes and escape genes the two alleles had no significant
difference in aggregate (Figure 3.13b).
3.3.7 Genome-wide allele-specific epigenome analysis
We then found regions that have a significant difference in methylation or
accessibility between paternal and maternal alleles, resulting in 9,997 differen-









































Figure 3.12: Haplotype phasing results on GM12878 nanoNOMe data. (a) The
number of reads that could be phased into maternal or paternal read based on the
presence of heterozygous SNV in the read, showing that 65% of reads could be phased.
(b) The fractions of the chromosomes that could be phased (the fraction that had > 10x
coverage on each allele after phasing) shows on average, 86% of the genome could be
phased.
(DARs) across the genome (Supplementary Figure 3.20a). While overlaps be-
tween DMRs and DARs were not common (629 overlaps, 6%), the overlapping
regions showed strong concordance (Supplementary Figure 3.20b). In the X
chromosome, we observed a disproportionate number of hypermethylated
81
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Figure 3.13: Allele-specific epigenetics in X chromosome inactivation. Methylation
and accessibility were separated by parent of origin, and (a) metaplots of TSS methy-
lation and accessibility were generated for each allele, showing the difference in XCI,
and (b) boxplots of methylation and accessibility in 500 bp and 100 bp windows,
respectively, centered at TSS compared between maternal and paternal alleles.
Xa DMRs (4564 hyper- vs 401 hypo-), agreeing with previous findings that
Xa is hypermethylated compared to Xi (Hellman and Chess, 2007). We also
found that the majority (N=1050; 80%) of DARs had higher accessibility in Xa,
showing that inactivation results in higher overall accessibility of Xa.
To assess the genomic context of DMRs, DARs, and concordant differential
regions in XCI, we calculated the enrichment of these regions in various
genomic contexts in the X chromosome (Figure 3.14). The enrichment of DMRs
with higher Xi methylation near TSS (500 bps upstream and downstream) and
the high number of DMRs in gene bodies with hypermethylated Xa agreed
with previous findings (Supplementary Figure 3.21a) (Hellman and Chess,
2007; Sharp et al., 2011). However, we found that the high number of DMRs in
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gene bodies was due to the larger size of gene bodies, and hypermethylated
Xa DMRs were enriched in enhancers. DARs mostly had higher accessibility
in Xa, and this pattern was consistent in all assessed genomic contexts. DARs
were enriched in CTCF binding sites in addition to promoters, suggesting that
the higher accessibility, and consequently increased affinity for CTCF binding,
work in concert to prevent XCI in Xa. Concordant regions with both a DAR
and DMR were heavily enriched near TSSs and 90% of them indicated higher
activity in Xa(307 out of 339). In autosomes, DMRs, DAR, and concordant
differential regions all occurred mostly in gene bodies and around TSS, with











































































































































Figure 3.14: Enrichment of allele-specific differential epigenetic regions. Enrich-
ment of (left) DMRs, (center) DARs, and CDRs (right) were calculated at various
genomic contexts in the X chromosome, showing the enrichment of allele-specific
epigenetic patterns in promoters and regulatory elements.
We then identified genes that had a DMR or a DAR within 500 bp of the
TSS. 1,049 genes had a DMR, 868 genes had a DAR, and 245 of these genes
had concordant difference in methylation and accessibility near the TSS. 76%
(187) of the concordantly differential TSS were in the X chromosome, and all
but XIST, a gene known to be specifically active in Xi to promote inactivation
of Xi, and RF01880, an exon of the XIST gene, in chrX indicated activity
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in Xa (maternal allele). Out of the 56 autosomal genes, 8 were previously
identified imprinted genes (Jirtle, 1999; Morison, Ramsay, and Spencer, 2005).
We plotted ZNF597, one of the 8 known imprinted genes, as an example; it
had a hypermethylated and less accessible promoter in the maternal copy,
indicating that it is active in the paternal allele (Figure 3.15). In addition to the
TSS epigenetic states, we observed that the gene body exhibited the opposite




































Figure 3.15: Allele-specific per-read methylation and accessibility of an ZNF597.
Read-level methylation and accessibility plots of ZNF597, an imprinted gene with
allele-specific epigenetic patterns at the promoter of the gene.
3.3.8 Allele-specific epigenomics in heterozygous structural
variations
Our long nanopore reads also allow detection of structural variants, large
insertions, deletions, or transpositions hard to detect with conventional short-
read sequencing. We characterized epigenetic consequences of these SVs by
comparing epigenetic signals in heterozygous SVs, focusing on large deletions
and insertions, which were the most commonly occurring SV types. After
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filtering for SVs that strongly suggest heterozygous SVs (filtering method
outlined in (Methods 3.5.6), we identified 1,195 deletions and 1,167 insertions,
and compared methylation and accessibility near SV breakpoints between
the variant and reference alleles (Figure 3.16, Supplementary Figure 3.22).
We found that while the majority of the SVs (80% of deletions and 82% of
insertions) do not have a difference in methylation between the alleles, in
those that did have a difference, the variant allele tends to be hypomethylated
in deletions (173 hypo vs. 65 hyper-) and hypermethylated in insertions (84
hypo vs. 131 hyper). This suggests a relationship between structural variation



























Figure 3.16: CpG methylation in heterozygous structural variations. Pairwise com-
parison of reference and variant allele CpG methylation in 1 kb region around break-
points of heterozygous structural variations.
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3.4 Discussion
We have utilized the long reads obtained by nanoNOMe to explore a num-
ber of aspects in the epigenome. Accessibility signals from long reads span
multiple protein binding sites, generating footprints with lengths which allow
us to infer the type of protein occupying the region. Using this approach
coupled to known CTCF binding motifs, we have examined the relationship
between CTCF binding and epigenetic patterns of nearby regions. Further,
we have combined the ability to predict protein binding with combinatorial
promoter epigenetic states to show protein binding events that occur in cis
with specific promoter epigenetic states. We can use these tools to identify
differential epigenetic states and protein binding events between different
breast cancer cell lines, providing a new window on cancer gene regulation.
The ability to observe long-range interactions of epigenetic features will be
useful in studying epigenomes in heterogeneous populations and in aneu-
ploid genomes (Matzke, Mittelsten Scheid, and Matzke, 1999). Because of
the greater chance for long reads to encounter a heterozygous SNV, we can
phase our nanopore reads, generating fully phased methylation and accessi-
bility profiles of a human genome. We explored the phased X chromosome
to understand new features of the epigenetic profile of X-inactivation. Curi-
ously, the inactive X chromosome showed lower methylation than the active
X chromosome outside of the TSS regions (which were more methylated in
Xi), especially in enhancers. We directly demonstrated that the allele-specific
data is useful in observing parent-of-origin epigenetic features, such as X
chromosome inactivation and escape from inactivation, allele-specific activity
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of imprinted genes, and epigenetic differences near heterozygous structural
variations. We can also use such tools to explore how imprinting is initiated
and controlled, by examining the phased epigenome in different tissues and
different developmental stages. Lastly, we can phase heterozygous SVs with
our long reads, and compare the epigenome of alleles with and without the
SV. The ability to measure the phased epigenome will be of high utility for ex-
ploring allele-specific epigenetic states, a recognized feature of human cancers
(Tischoff et al., 2005; Avin et al., 2019).
3.5 Methods
3.5.1 Calculating and piling up co-occurrence of
accessibility and inaccessibility
To observe patterns of DNA methylation and accessibility in the presence
of biological heterogeneity and technical variability, co-occurrence of methy-
lated/unmethylated cytosine is calculated across reads that map to the ge-
nomic region of interest. Co-occurrence, c, is defined by the same event, M
(methylated or unmethylated) , occurring on two separate binned locations, i
and j, along a given read :
cij =
{
1, if Mi ≥ Mj
0, otherwise
After calculating the co-occurrence for each pair of coordinates for each
read, the counts are piled up to determine the frequency of co-occurrence as
a measure of how often reads have the same events occurring between the
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positions i and j. The resulting matrix of co-occurrence pileup is normalized
by the maximum count, and plotted as a 2-dimensional heatmap to visualize
the patterns (see accessions for code availability).
3.5.2 Estimating single-molecule accessibility calls using a
smoothing estimator
To remove isolated erroneous calls of accessibility on individual reads, we
applied a fixed-bandwidth Gaussian kernel smoothing on the log-likelihood
ratios (LLRs). First, LLR were capped at the calling thresholds (-1,1), forcing
all LLRs with absolute value greater than 1 to be -1 or 1, to prevent bias
from LLRs with large magnitudes. The adjusted LLRs were smoothed using
a Gaussian kernel with fixed bandwidths. Smoothed LLRs were called as
accessible (methylated) if the LLR > 0.4 and inaccessible (unmethylated) if the
LLR < 0.4.
3.5.3 Predicting regulatory protein binding from closed runs
To discriminate CTCF binding events from nucleosome binding events on
individual reads, we used lengths of closed runs on centers of CTCF binding
motifs. The lengths were clustered on Gaussian finite mixture models us-
ing Expectation-Maximization algorithm implemented by R package Mclust
version 5.4.5 (Scrucca et al., 2016). The optimal clustering parameters were
determined based on maximum integrated complete-data likelihood (ICL),
and the cluster that had the smallest mean length ( 54 bps) was chosen as
CTCF-binding signal and the other clusters as units of nucleosome-binding
signals. This model was applied to classify all closed runs within 25 bps of
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CTCF binding sites as CTCF-bound or nucleosome-bound and reads that
contained CTCF-bound closed runs were considered to be CTCF-bound reads.
To predict protein binding events outside of CTCF binding sites, we used the
model on all closed runs to categorize them to one of the clusters, using the
runs that were assigned into the smallest mean length cluster as candidates
for protein binding. We selected regions that contained at least ten candidates
as the predicted regions of protein binding events.
3.5.4 Predicting combinatorial promoter epigenetic states on
individual reads
To predict combinatorial epigenetic states of individual reads on TSS, we
used methylation and accessibility in a window around the TSS. On each
read that spans a TSS, we calculated average CpG methylation over the 1kb
region around the TSS and GpC methylation over 200 bps around the TSS.
The two epigenetic signals were separately clustered into two clusters of
high and low average signals using the Expectation-Maximization algorithm
on Gaussian finite mixture models as used above to generate probabilistic
models of the epigenetics states. On individual reads, CpG methylation and
GpC accessibility were separately clustered using the resulting models, and
the combinatorial epigenetic state of reads was determined based on the
combination of the cluster assignments.
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3.5.5 Interactions of promoter epigenetic states and protein
binding
Read-level protein-binding estimation and promoter epigenetic state estima-
tion were coupled by first estimating regions of protein binding within 10kb
of TSSs of a subset of genes. Sites that have 10 or more reads with short
closed runs in a window less than 80 bp were selected as estimated protein-
binding regions. We then separated the reads based on the epigenetic state
of nearby gene promoter(s), and separately assessed the reads that suggest a
protein-binding event at the protein-binding region in each group, resulting
in protein-bound reads specific to each promoter epigenetic state.
3.5.6 Haplotype Assignment and Allele-Specific
Methylation Analysis
We obtained genotype information for GM12878 from existing phased Illu-
mina platinum genome data generated by deep sequencing of the cell donors’
familial trio (Eberle et al., 2016). Bcftools version 1.9 was used to filter for
only variants that are heterozygous in GM12878 (Li, 2011). The heterozygous
GM12878 SNVs were used to identify reads with allele-informative variants
and assign the parent of origin for each read using WhatsHap version 0.18
(Patterson et al., 2015). Methylation and accessibility calls on each read were
separated based on the haplotype assignments to generate allele-specific pro-
files of methylation and accessibility. To identify accurate heterozygous SVs,
we called SVs on the two alleles separately using Sniffles version 1.0.11 and
SURVIVOR version 1.0.7 using default parameters (Sedlazeck et al., 2018).
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From the resulting merged vcf, we selected heterozygous SVs by selecting
the SVs that have less than 2 non-variant and more than 20 variant reads on
only one of the alleles. To remove SVs that are short in length or affected by
incorrect alignments, we removed SVs that are shorter than 200 bps and have
more than 100 read alignments in one allele.
3.5.7 Bresat cancer cell line analysis
RNA-seq counts of the three cell lines were downloaded from GEO accession
GSE75168 and analyzed using the bioconductor packager DESeq2 version
1.24.0 (Messier et al., 2016; Love, Huber, and Anders, 2014). Using default
parameters, differential expression analysis was performed based on the
negative binomial distribution, comparing MCF-7 and MDA-MB-231 to MCF-
10A. Genes were considered to be significantly differentially expressed when
the Bonferroni-Hochberg corrected p-values were less than 0.01.
Of this differentially expressed set, we filtered for genes with 5 or more
differences between normal and cancer lines in the number of reads indicating
epigenetically concordant active promoters. Then the protein binding states
were compared on predicted protein-binding regions within 10kb of the TSS
of these genes, and the fraction of reads that have protein binding were
calculated for each sample. Those regions that had a difference of protein
binding fraction >= 0.4 were selected as genes with differences in the promoter
epigenetic states and protein binding.
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Figure 3.17: Single-molecule closed run lengths at CTCF binding sites. (a) Density
distributions of closed runs at the CTCF binding sites, showing that sites without
CTCF binding have long closed runs suggesting nucleosome binding while those with
CTCF binding have short closed runs suggesting CTCF binding, and (b) using the
length of runs at CTCF binding sites to discriminate inaccessibility due to regulatory
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Figure 3.18: Assessment of read-level combinatorial epigenetic states of TSS. Frac-
tions of read-level combinatorial epigenetic states at TSS were calculated for each
TSS in a subset of 1,000 genes per group and compared (a) by expression quartiles,
showing that with increasing expression more genes have higher fraction of combina-
torially active reads and less fraction of inactive reads, and (b) by promoter histone
modification, showing that reads at euchromatic H3K4me3 genes are demethylated
and reads at heterochromatic H3K27me3 genes are inaccessible.
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Haystack Motif Enrichment Analysis Tool
Motifi







in BGi    Ratioi   
p-
valuel   
q-
valuel   
Centrall
Enrichmenti   
Motifi
Profileil   Logo  
MA0139.1 CTCF 16.05% 3.98% 3.42 2.08e-112
6.87e-
111 3.82
MA0751.1 ZIC4 7.97% 4.76% 1.56 2.13e-12
1.41e-
11 1.81
MA0696.1 ZIC1 7.14% 4.07% 1.61 6.80e-13
5.61e-
12 1.76
MA0506.1 NRF1 7.70% 3.61% 1.89 1.02e-21
1.69e-
20 1.76
MA0697.1 ZIC3 6.93% 4.76% 1.38 9.33e-07
3.08e-
06 1.66
MA1099.1 Hes1 3.55% 1.59% 1.75 1.99e-11
1.10e-
10 1.66
MA0116.1 Znf423 3.14% 2.16% 1.31 1.18e-03
2.05e-
03 1.64
MA0632.1 Tcfl5 3.02% 1.06% 1.95 3.17e-14
3.48e-
13 1.59
MA0872.1TFAP2A(var.3) 5.29% 3.95% 1.27 6.94e-04
1.28e-
03 1.58
MA0813.1TFAP2B(var.3) 5.07% 3.84% 1.25 1.56e-03
2.57e-
03 1.55
Haystack was built by Luca Pinello 
Figure 3.19: Results of Haystack Bio motif enrichment on candidate protein bind-
ing sites. Candidate protein binding sites were selected from closed accessibility runs.
Haystack Bio motif enrichment was ran on these regions to detect enrichment of these
regions in transcription factor binding sites from JASPAR database.
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Figure 3.20: Differentially methylated and differentially accessible regions be-
tween alleles in GM12878. Methylation was compared between the two alleles
across the genome to find regions of significant difference and were tested using
one-sided FisherâĂŹs exact test, and accessibility peaks were compared by 1) finding
peaks of accessibility on each allele separately, 2) selecting peaks that occur exclu-
sively in one allele, 3) and comparing the accessibility frequency between the two
alleles in these candidate regions. The detected DMRs and DARs are (a) shown as
volcano plots, with dashed lines representing thresholds for considering the region as
DMR/DAR. (b) Directions of DMRs/DARs as well as their overlaps were observed
using upset plots, across the genome (left), as well as separated by autosomes (middle)
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Figure 3.21: Genome-context enrichment of allele-specific differential epigenetic
regions. (a) Numbers of differential regions in each genomic context in X chromo-
some, (b) Numbers of differential regions in genomic contexts in autosomes, and (c)
enrichment of differential regions in autosomes
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Figure 3.22: Allele-specific epigenetic comparison of heterozygous structural vari-
ations. (a) Pair-wise comparison of GpC methylation around breakpoints of heterozy-
gous SVs, with the allele with the SV on the y-axis and the allele without the SV on
the x-axis. The difference of CpG methylation and GpC methylation in variant alleles
of SVs in comparison to the reference alleles, with one-sided FisherâĂŹs exact tests
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Chapter 4
Targeted sequencing on nanopore
sequencing platform
Isac Lee, Rachael Workman, Winston Timp, Josh Zhiyong Wang. Use of Agi-
lent SureSelect to perform targeted long-read nanopore sequencing. Agilent
Application Note (2017) doi:10.17504/protocols.io.zxyf7pw
4.1 Abstract
Targeted enrichment of DNA in genomic regions of interest is a cost-effective
method to perform deep sequencing on multiple samples. Targeted sequenc-
ing is widely used in Next Generation Sequencing (NGS), e.g. exome sequenc-
ing. Here I implemented of targeted nanopore sequencing and discuss the
challenges and advantages. By adapting solution-phase hybridization capture
to nanopore sequencing, we can achieve > 300-fold enrichment in DNA se-




The explosive advances in DNA sequencing technologies has made it a uni-
versal tool for biology with applications in a wide range of studies. However,
regardless of how cheap sequencing is, a more cost-effective methodology
for sequencing the DNA to a great depth is always favorable, especially in
organisms with large genomes such as humans. One of the ways to make an
efficient use of the sequencing is to selectively sequence parts of the genome
that is important in the biological question. In fact, we have not yet uncovered
the function of the vast majority of the genome, so much of the data in whole
genome sequencing is seemingly wasted (Salzberg, 2019). Several approaches
for targeted enrichment have been established, including PCR, tagmentation
(fragmentation by transposase), and solution-phase hybridization capture
(Kozarewa et al., 2015).
The most obvious benefit of targeted sequencing is the reduction in cost.
Because large numbers of samples can be sequenced with low amount of input
using targeted sequencing, it has been used in large biobank consortia and
clinical studies. Multiple biobanks have sequenced whole exomes of over 1,000
individuals using exome sequencing, associating exon mutations with disease
phenotypes (GTEx Consortium et al., 2017; Van Hout et al., 2019). Panels
for specifically targeting cancer-associated regions in the genome have been
developed and applied to clinical studies, allowing comprehensive mutation
studies of cancer driver mutations across large number of patients as well
as prevention and early detection of cancers (Nikiforova et al., 2013; Muller
et al., 2016; Lee et al., 2015). In addition, targeted sequencing yields high
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depth of sequencing, allowing more accurate measurements of mutations in
the regions of interest.
One of the most popular target enrichment methods available is from
Agilent Technologies: the SureSelectXT solution-phase hybridization-capture
system (Figure 4.1). In addition to predetermined panels of capture probes,
the user can utilize custom capture libraries with 120nt biotinylated RNA
baits to enrich genomic regions ranging from less than 50 kb to over 100
Mb for deep sequencing of specific genomic regions. With probe designs
generated by their design algorithms, which considers complicated factors
such as sequence complexity and GC content, it is possible to perform DNA
enrichment and sequencing in a highly efficient, cost-effective manner. Here
we present our adaptation of the Agilent Sureselect system on nanopore
sequencing to sequence tumor suppressor genes CDKN2A and SMAD4. We
demostrate its ability to deeply sequence regions of interest and use it to detect
structural variations and phase single nucleotide variations.
4.3 Results
4.3.1 Solution-phase hybridization capture nanopore
sequencing
We have applied the Agilent SureSelectXT protocol to nanopore long-read
sequencing. Note that the vast majority of conventional DNA sequencing
library preparation protocols are geared toward creating short, 200 - 300
bp DNA fragments, tailored to short-read second generation sequencing,













Figure 4.1: Overview of solution-phase hybridization capture. 1) Genomic DNA
is sheared and ligated to amplification adaptors. 2) the adaptor-ligated DNA is
incubated in solution phase with RNA probes that are complementary to the region of
interest and are also biotinylated. 3) Streptavidin-coated magnetic beads are bound to
the biotin molecules on the RNA molecules which are in turn hybridized to the region
of interest. 4) magnets are used to pull down the streptavidin-coated beads, which
selectively retains DNA molecules that are in the region of interest. 5) After washing
away non-hybridized DNA, the DNA molecules are amplified by PCR, resulting in
enriched DNA pool
sequencing, we adjusted the protocol, altering the shearing conditions to
generate DNA fragments with a size distribution centered at 2kb and PCR
conditions to allow for amplification of the long DNA strands. The probe
design was optimized using Agilent’s probe design algorithm and validated
experimentally to increase the on-target percentage. Optimizations to the
probe design include strategic placement of probes with appropriate, i.e.
larger, probe spacing to enrich for larger regions, utilization of stringent
probes to decrease non-specific binding, and increased number of probes
around regions previously determined to contain SVs.
We applied the modified SureSelectXT protocol on 3-4µg of NA12878
lymphatic cell line gDNA as a control. In addition to the control DNA, we
obtained patient-derived pancreatic ductal adenocarcinoma (PDAC) cell lines
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and performed the same targeted sequencing on gDNA of these cell lines
to examine the performance of the method in real samples. We performed
nanopore sequencing on the enriched libraries using Oxford MinION. From an
average of 200Mb (100k reads) total sequencing output, we achieved 30 % on-
target percentage, yielding an average of >300-fold enrichment in the targeted
region (Figure 4.2, Table 4.1). To validate the performance of the hybridization
capture protocol, the control NA12878 DNA was sheared to 200 bp fragments
and selected using the original SureSelect protocol with the same probes, and
then sequenced via Illumina short-read sequencing on MiSeq sequencing
platform. As shown in F
¯
igure 4.2, the alignment coverage over the targeted
























































Figure 4.2: Nanopore and Illumina sequencing coverage of the capture regions.
Coverages of nanopore and Illumina sequencing using solution-phase hybridization







Illumina NA12878 4.4m 3.7m 85% 641X 113X
Nanopore NA12878 107k 32k 30% 353X 27X
Nanopore PDAC 56k 20k 26% 332X 20X
Table 4.1: Nanopore and Illumina targeted sequencing metrics. Sequencing metrics
of Illumina and nanopore sequencing on NA12878 and nanopore sequencing on
PDAC cells using solution-phase hybridization capture system.
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4.3.2 Detecting nucleotide variations using targeted
sequencing
We then detected structural variations (SVs) and single nucleotide variations
(SNVs) from the targeted data. We used three approaches in SNV detection
to examine whether nanopore sequencing can be effective in detecting SNVs
: samtools on Illumina sequencing dataset to serve as the gold-standard
approach, nanopore sequencing reads with samtools, and using the raw signal
to detect SNVs using nanopolish. Nanopolish corrects errors on the aligned
sequences via a hidden Markov Model, wherein the observed output is the
k-mer current signal, the states are the true nucleotide sequence, and the
conditional probabilities are dependent on the previous state, k-mer current
signal, as well as the sequence of the reference alignment (Loman, Quick,
and Simpson, 2015). SNV calling on the error-corrected sequences of the
control NA12878 yielded 1,017 SNVs, of which 947 were in agreement with
the SNVs for the same cell line published via Platinum Genomes Project
(Eberle et al., 2016). When compared to the 4,138 SNVs called with raw
nanopore data, only 2,485 of which were in agreement with published SNV
data, we determined that the majority of the inaccurate SNVs are filtered
out through error-correction (Table 4.2, example SNVs shown in Figure 4.3a).
SNV analysis of Illumina sequencing data resulted in 1,211 SNVs, of which
1,133 matched the published data. Therefore, with the high depth provided
by targeted sequencing, we can achieve the performance of SNV detection in
nanopore sequencing that matches NGS. Moreover, using the long reads of
nanopore sequencing, we detected de novo heterozygous SNVs and phased
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Figure 4.3: SNV analysis using targeted nanopore sequencing. (a) Comparison of
detected SNVs and pileup of mismatch in the raw nanopore reads for a 2,000bp
window along with mismatch frequencies in the nanopore sequencing data, and (b)
phased SNV analysis by detecting heterozygous SNVs and phased using the long
reads of nanopore sequencing
Illumina Pre-polish Post-polish
Avg. Coverage 113 27 27
Correct 1133 2485 947
Total 1211 4138 1017
Precision 94% 60% 93%
Sensi�vity 32% 69% 26%
Table 4.2: SNV detection metrics in the targeted regions of interest for three ap-
proaches. Calculated precision and sensitivity of Illumina sequencing and the two
approaches of nanopore sequencing in detecting single nucleotide variations.
We then detected structural variations using sniffles (Sedlazeck et al., 2018).
From the control NA12878 data, 6 SVs were detected in the CDKN2A region
and 3 in the SMAD4 region. These SVs were compared to a list of SVs detected
via 100x depth whole-genome PacBio long-read sequencing, provided by
the Genome In A Bottle consortium, demonstrating that targeted nanopore
sequencing captures SVs within the region of interest (Supplementary Figure
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4.5). We then detected SVs in the PDAC samples, finding two putative SVs,
one in each of the two regions (CDKN2A and SMAD4) (Figure 4.4). One
SV was present in only a subset of reads, indicating that this SV can be a
heterozygous SV. The other SV was a homozygous deletion that spanned a
large chunk of the CDKN2A (approximately chr9:21,950,000-22,450,00), which
was previously discovered by Norris et al (Norris et al., 2015). These SVs on
tumor suppressor genes indicate a loss-of-function in these genes, thereby
promoting abnormal cellular growth, one of the hallmarks of cancer (Hanahan
and Weinberg, 2011).
4.4 Discussion
Targeted sequencing has proven to be a cost-effective method to sequence
large number of samples using NGS. We have demonstrated that the same
hybridization capture technique used in NGS can be adapted, with modifi-
cations, to nanopore sequencing. Using the nanopore hybridization capture
sequencing methodology, we have sequenced two tumor suppressor genes to
high depths, allowing us to scrutinize genomic anomalies that are present in
these genes. When targeting a 2.4 Mbp region (1.5 Mbp for CDKN2A gene and
850 kbp for SMAD4), which is less than 0.5 % of the genome, 30 % on-target
was achieved reliably from nanopore sequencing.
We have shown that this targeted sequencing data can be used to detect
SNV and SV detection using nanopolish and sniffles algorithms. With high
sequencing depth, the accuracy of SNV calls are dramatically increased and
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Figure 4.4: Structural Variation detection in targeted nanopore sequencing of Pan-
creatic Ductal Adenocarcinoma. Structural variations were detected in the targeted
nanopore sequencing data of PDAC cell lines
for SNV detection. In addition, the longer reads allows phasing of heterozy-
gous SNVs. As expected, SV detection, which is challenging even with high
depth sequencing and intense computational processing from short-read data,
is efficient and cost-effective using long-read sequencing coupled with the tar-
get enrichment. Applying this technique on patient-derived pancreatic ductal
adenocarcinoma cells, we have shown that targeted nanopore sequencing can
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be used to detect disease-causing mutations. We have shown that there are
SVs in the two targeted tumor suppressor genes, possibly leading to increase
in tumor cell growth.
The hybridization capture protocol is currently optimized for 5 kb long
reads. While this length is longer than in Illumina sequencing, it is much
lower than the length nanopore sequencing is able to handle. Both the phased
SNV and SV detection using this technique can be improved with further
optimization of the protocol, e.g. enrichment of even longer DNA fragments.
In addition, because this protocol enriches for the targeted DNA by PCR am-
plification, covalent modifications, such as the endogenous CpG methylation,
are stripped away. A protocol that removes the need to amplify the DNA
will both increase the length of reads as well as allow detection of covalent
modifications from nanopore sequencing. In fact, we hav demonstrated the
use of the CRISPR-Cas9 system to selectively sequence DNA in the region
of interest using nanopore sequencing (Gilpatrick et al., 2020). While the
enrichment is not as high as in hybridization capture, this method allows
sequencing of long molecules with covalent modifications.
The utility of targeted sequencing has been shown in large scale and
clinical studies. The high utility of targeted sequencing is directly translatable
to nanopore sequencing : with large scale studies using targeted nanopore
sequencing, we will be able to further our understanding of the role of the




4.5.1 Agilent Sureselect XT Targeted Enrichment
The enriched DNA library used in nanopore sequencing library preparation
was generated using the standard Agilent Sureselect XT protocol with the
following modifications. First, the DNA shearing was optimized for fragmen-
tation centering at 5 kb. We used a Bioruptor Pico (Diagenode), shearing 130
µL of 5-50 ng/µL purified genomic DNA in 1.5 mL tubes with 5 cycles of 4
seconds on and 30 seconds off. After end-repair and adaptor ligation, ampli-
fication was performed using PCR reagents and conditions optimal for the
long fragments. Specifically, we used NEB LongAmp Taq with the following
PCR protocol: 30 seconds at 94°C, 8 cycles of 20 seconds at 94°C, 30 seconds at
55°C, and 3 minutes at 65°C, then final extension of 10 minutes at 65°C. The
adaptor-ligated 2kb DNA library underwent RNA probe hybridization and
capture. Finally, we performed another round of PCR, using NEB LongAmp
Taq: 3 minutes at 94°C, 14 cycles of 15 seconds at 94°C, 30 seconds at 60°C, 3
minutes at 65°C, then final extension of 10 minutes at 65°C. As a quality check,
we profiled the size distribution and yield on the Bioanalyzer. We used the
enriched DNA for Oxford Nanopore Technologies (ONT) DNA sequencing li-
brary preparation. Briefly, the DNA fragments were dA-tailed using NEBNext
DNA Ultra II reagents and cleaned up with AMPure XP beads. Then, the ONT
adaptors were ligated using NEB Blunt/TA ligation master mix. After the
final AMPure XP cleanup, the prepared ONT sequencing library was loaded
and sequenced per ONT’s protocol.
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4.5.2 Data preprocessing
Illumina sequencing data was aligned to hg38 human reference genome using
bowtie2 with default parameters. Nanopore sequencing data was aligned to
the same genome using bwa “mem” module using the pre-tuned options for
aligning Oxford Nanopore reads (-x ont2d). In both datasets, samtools was
used to sort and convert the resulting data into bam files.
4.5.3 Variant detection using targeted nanopore data
Nanpolish was used to perform error correction using the alignment and the
raw sequence. The same set of inputs, along with the output from nanopolish,
were used to either call SNVs or build consensus sequence using nanopolish.
On Illumina sequencing data and on nanopore sequencing data without error-
correction, we used samtools mpileup and bcftools to obtain the putative
SNVs. Structural variations were detected using a structural variance caller
sniffles using the bwa-mem output bam file, resulting in a variant call format
(vcf) file containing loci of putative SVs.
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Figure 4.5: Structural Variation detection in targeted nanopore sequencing of
NA12878. Structural variations were detected in the targeted nanopore sequenc-
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I have described my work in using nanopore sequencing to explore the hu-
man epigenome. Using exogenous labeling of nuclei with GpC methylation, I
simultaneously measured CpG methylation and chromatin accessibility, reca-
pitulating comparable NGS methods and examining parts of the genome that
are difficult or impossible to study with conventional NGS methods. With
more complete assemblies of the human genome, using the nanoNOMe data
directly or other long-read data, we will be able to more accurately examine
epigenetic features of repetitive regions and large-scale genomic rearrange-
ments. In fact, Long-read technologies have begun to do so, showing patterns
of CpG methylation in centromeric regions of chromosomes and demon-
strating the potential significance of the epigenome in these regions (Miga
et al., 2019). The ability to assemble the genomes of individual samples using
nanoNOMe, resolving genomic variations and their epigenome, will allow
more comprehensive understanding of the differences between individuals.
We can also use nanopore sequencing to sequence long RNA products of the
corresponding cells and integrate with nanoNOMe, directly examining the
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relationships of the genome, epigenome, and the transcriptome (Workman
et al., 2019).
With rapid advancements of nanopore sequencing technology, additional
modifications of DNA beyond GpC methylation could be added to this
method (McIntyre et al., 2019). Through the incorporation of additional
methyltransferases, (e.g. EcoGII which methylates adenine to N6-methyladenine),
it is possible to introduce additional labels in yet another context of the
epigenome (Shipony et al., 2020). Such a technique could also provide a
“multi-color” measurement, allowing further aspects of the epigenome to
be interrogated on the same molecule. Others have already leveraged this
methyltransferase fused to lamin protein to explore nuclear architecture but
are limited to enzymatic cleavage before sequencing, precluding observation
of long-range interactions on a single molecule resolution (Wu, Olson, and
Yao, 2016). With further training and development, it may be possible to lever-
age combinatorial exogenous labeling with nanopore sequencing to ascertain
multiple features about chromatin architecture to gain long-range, phased
information.
The heterogeneous nature of the epigenome suggests that higher depth
would be a key advantage at specific loci. I have shown that targeted se-
quencing achieves higher depth of sequencing in specific parts of the genome
and can be a cost-effective method to study large cohorts of samples. The
impact of targeted sequencing would be even greater when coupled with the
ability of nanopore sequencing to examine the epigenome. In fact, we have
recently developed an improved targeted sequencing method that retains
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the modifications on the DNA molecules while achieving >1000X deep se-
quencing with >20kb long reads (Gilpatrick et al., 2020). With optimizations,
nanoNOMe can be streamlined with nCATs, giving us the ability to probe
the epigenome of specific regions of the genome with high depth and longer
reads. With higher depth, we can more accurately quantify protein binding
and promoter epigenetic states and better examine the heterogeneous nature
of the epigenome, e.g. differences in protein binding, nucleosome positioning
and DNA methylation within a population of cells. The longer reads will
allow us to observe cis interactions of protein binding and epigenetic states in
more distant loci and understand the association of the epigenetic features in
longer distances.
These added capabilities from coupling nanoNOMe - and further exten-
sions of exogenous labeling epigenomic assays - with nCATs will be especially
important in observing the epigenome of primary tissue samples. A tissue
contains multiple cell types, each of which often have distinct epigenomic
profiles (Roadmap Epigenomics Consortium et al., 2015). By resolving multi-
ple epigenetic layers, we can measure the epigenetic heterogeneity in tissue
samples and observe the combinatorial epigenetic states in disease-relevant
regions on individual DNA strands. This will lead to more comprehensive
characterizations of the epigenetic changes during disease progressions and
further our knowledge of the mechanisms of diseases.
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